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SUMMARY The advent of heme during evolution allowed organisms possessing this
compound to safely and efﬁciently carry out a variety of chemical reactions that oth-
erwise were difﬁcult or impossible. While it was long assumed that a single heme
biosynthetic pathway existed in nature, over the past decade, it has become clear
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that there are three distinct pathways among prokaryotes, although all three path-
ways utilize a common initial core of three enzymes to produce the intermediate
uroporphyrinogen III. The most ancient pathway and the only one found in the
Archaea converts siroheme to protoheme via an oxygen-independent four-enzyme-
step process. Bacteria utilize the initial core pathway but then add one additional
common step to produce coproporphyrinogen III. Following this step, Gram-positive
organisms oxidize coproporphyrinogen III to coproporphyrin III, insert iron to make
coproheme, and ﬁnally decarboxylate coproheme to protoheme, whereas Gram-
negative bacteria ﬁrst decarboxylate coproporphyrinogen III to protoporphyrinogen
IX and then oxidize this to protoporphyrin IX prior to metal insertion to make proto-
heme. In order to adapt to oxygen-deﬁcient conditions, two steps in the bacterial
pathways have multiple forms to accommodate oxidative reactions in an anaerobic
environment. The regulation of these pathways reﬂects the diversity of bacterial me-
tabolism. This diversity, along with the late recognition that three pathways exist,
has signiﬁcantly slowed advances in this ﬁeld such that no single organism’s heme
synthesis pathway regulation is currently completely characterized.
KEYWORDS heme, biosynthetic pathways, metabolic regulation, pathway evolution,
tetrapyrroles
INTRODUCTION
With the exception of a few organisms, tetrapyrroles are ubiquitous in theirdistribution in nature. While most commonly found as metallated macrocycles,
biologically signiﬁcant linear forms such as bilins also exist, which play important roles
as both photosynthetic accessory pigments and photopigment photoreceptor proteins.
The metallated modiﬁed tetrapyrroles are involved in nearly all the major metabolic
and respiratory processes found in biological systems, from photosynthesis to metha-
nogenesis. From a prokaryotic perspective, the ability to make modiﬁed tetrapyrroles
enriches the metabolic capacity, providing ecological advantages and allowing the host
to rapidly switch between environmental conditions. It is no coincidence, therefore,
that the richest diversity of tetrapyrrole compounds is found among microorganisms
that generally possess all the necessary enzymatic machinery to synthesize their own
complement of modiﬁed tetrapyrroles.
The metallated modiﬁed tetrapyrrole fraternity includes among its members the
hemes, the chlorophylls and bacteriochlorophylls, the corrins (vitamin B12), siroheme,
coenzyme F430, and heme d1. Most of these molecules are associated with just one key
process. For instance, the chlorophylls and bacteriochlorophylls are the light-absorbing
pigments that are the essential components of oxygenic and anoxygenic photosyn-
thesis, respectively (1). Similarly, siroheme, an Fe-containing isobacteriochlorin, acts as
a prosthetic group in the six-electron reduction of either sulﬁte or nitrite in assimilatory
sulﬁte and nitrite reductase. Coenzyme F430, a yellow-colored nickel-containing mod-
iﬁed tetrapyrrole, plays an essential role in the ﬁnal step in methanogenesis in the
enzyme methyl coenzyme M (CoM) reductase (2). Heme d1, which is technically not a
heme but an Fe-containing dioxoisobacteriochlorin, is a prosthetic group in the cyto-
chrome cd1 nitrite reductase (3). In contrast, the corrins and hemes are functionally
much more diverse. Biological corrins, which are sometimes referred to as cobamides,
cobalamins, and vitamin B12, possess a cobalt-containing corrin macrocycle. These
molecules play a role in at least four major classes of enzymes, including B12-dependent
isomerases, methyltransferases, reductive dehalogenases, and radical S-adenosyl-L-
methionine (SAM) enzymes (4). Moreover, adenosylcobalamin has recently been shown
to play a role as a light sensor in the control of transcription (5). However, the most
versatile and ubiquitous metalloprosthetic group is heme. It is known to play roles in
gas sensing and transport, catalysis, signaling, electron transport, and transcription (6).
This review explores how heme, an Fe-containing porphyrin, is made in bacteria and
archaea but in so doing also highlights how the other Fe-containing modiﬁed tetrapyr-
roles, siroheme and heme d1, are constructed.
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In the Bacteria, de novo heme biosynthesis appears to have been developed
evolutionarily very early, by the time that deep-branching phyla such as the Plancto-
mycetes or Aquificae had diverged. The absence of the pathway (or incomplete path-
ways) in various bacterial pathogens and symbionts appears to result from secondary
gene losses. In free-living organisms, the absence of the protoheme biosynthetic
branch is not uncommon; however, the total absence of the de novo synthesis of all
tetrapyrroles is almost nonexistent. Exceptions are extremely few and include only
genera at the root of the bacterial phylogeny: Dehalococcoides and Thermotoga. The
loss of tetrapyrrole biosynthesis in the Thermotogaceae appears secondary (in spite of
the fact that it is missing in all Thermotoga genomes available to date), since the
genome of Thermosipho melanesiensis contains the full complement of genes for the
biosynthesis of uroporphyrinogen (URO) III (the last common precursor of various
tetrapyrrolic cofactors) and several porphinoids.
The core pathway for the biosynthesis of tetrapyrroles is an ancient one (Fig. 1). Two
distinct mechanisms to synthesize the ﬁrst committed pathway intermediate,
5-aminolevulinic acid (ALA), have evolved, but the next three enzymes, porphobilino-
gen (PBG) synthase (PBGS), hydroxymethylbilane (HMB) synthase (HMBS), and uropor-
phyrinogen synthase, are highly conserved, being found in archaea to eukaryotes.
Indeed, these three enzymes can be considered the trunk of the biological tetrapyrrole
synthesis tree. The end product of this core pathway, uroporphyrinogen III, serves as
the precursor to the synthetic branches for the Ni-containing F430 that is utilized in
archaeal methanogenesis (7, 8): the Co-containing corrin that is an important nutrient
in the form of vitamin B12 but synthesized by a limited number of archaea and
eubacteria (9, 10), the Fe-containing siroheme (11, 12), heme d1 and protoheme (13,
14), and the Mg-containing chlorophylls and bacteriochlorophylls found in photosyn-
thetic organisms (15). A casual examination of these pathways and the branches of life
in which they are found makes clear that the order of appearance in evolution must be
F430 and cobalamin ﬁrst, followed by siroheme, then protoheme, and ﬁnally chloro-
phyll. Indeed, while it is generally stated that the advent of chlorophyll-based photo-
synthesis was an early and key evolutionary event, it is obvious that highly varied life
existed well before nature happened upon protoporphyrin, the key building block for
this compound. Additionally, the presence of oxygen respiration in Gram-positive
bacteria, which predated Gram-negative bacterial chlorophyll synthesis, suggests that
the generation of oxygen by other means, such as by the hemoprotein enzyme chlorite
dismutase, may have played more signiﬁcant roles than generally credited (16).
FIG 1 Tetrapyrrole biosynthetic pathways in prokaryotes. An outline of prokaryotic tetrapyrrole
biosynthetic pathways is shown with the conserved three-enzymatic-step core path from ALA
(5-aminolevulinate) to uroporphyrinogen III boxed in blue. Among prokaryotes, one ﬁnds one of two
generally nonoverlapping paths to ALA. The synthesis of ALA from glutamyl-tRNA (5-carbon pathway) is
most common, with a limited number of bacteria possessing the enzyme AlaS to form ALA from glycine
and succinyl-CoA (4-carbon pathway). The 4-carbon pathway to ALA is found only in bacteria that
possess the protoporphyrin-dependent pathway branch. Uroporphyrinogen III is the precursor to
Ni-containing F430 in methanogens, Co-containing cobalamin, and Fe-containing siroheme and heme d1
as well as coproporphyrinogen, which is the common precursor of Fe-containing protoheme and
Mg-containing chlorophylls. Abbreviations: PBG, porphobilinogen; HMB, hydroxymethylbilane; uro’gen
III, uroporphyrinogen III.
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Iron-containing porphyrins (hemes) (Fig. 2) are widely distributed, being found in
eukaryotes, most characterized bacteria, and some archaea. The functions served by
hemes are diverse and dependent upon the nature of the heme moiety and the protein
to which it is bound. Many bacteria contain a diversity of environmentally regulated
heme-containing respiratory cytochromes in which the heme has a redox function as
a one-electron carrier (17). There are other non-respiratory-chain cytochromes, such as
cytochrome P450s, which utilize protoheme as a cofactor to metabolize a broad range
of substrates, most commonly serving as a monooxygenase (18). There are also some
noncytochrome hemoproteins, such as the enzyme chlorite dismutase, which converts
chlorite to chloride and molecular oxygen (19), and may serve as individual respiratory
proteins. Another class of hemoproteins in bacteria serves as gas sensors. Unlike the
respiratory proteins, the heme of gas-binding hemoproteins does not undergo a redox
reaction. Examples of these are the well-characterized CO-sensing CooA transcription
factor (20), nitric oxide/oxygen-sensing (H-NOX) proteins (21), globin-coupled oxygen
sensors (22), and the DosS and DosT gas sensors of Mycobacterium tuberculosis (23).
Additionally, many eubacteria possess heme-containing peroxidases and catalases. In
some photosynthetic bacteria, endogenously synthesized protoheme serves as the
substrate for heme oxygenase in the synthesis of the linear tetrapyrrole biliverdin as a
precursor to the photosynthesis accessory pigments named phycobilins (24).
Most bacteria that contain heme possess the necessary machinery to synthesize it.
However, this is not universal, since a few bacteria, such as Enterococcus faecalis and
lactic acid bacteria (25), possess genes encoding apohemoproteins but cannot synthe-
size their own heme (26, 27). They are instead equipped to acquire and utilize
exogenously supplied heme for incorporation into these apoproteins to make the
mature hemoprotein. Many bacteria have heme acquisition systems whose main
function is to procure heme for subsequent degradation and release of iron (28, 29).
The ﬁelds of heme trafﬁcking and degradation are diverse, rapidly expanding, and
outside the scope of this review.
Research on heme biosynthesis dates back over 50 years and is summarized in the
FIG 2 Structures of protoheme IX, coproheme III, uroporphyrinogen III, siroheme, and heme d1. The structure of protoheme
IX is shown with the four pyrrole rings labeled by convention as rings A, B, C, and D. The numbering of side chains is also
shown. Of note is that the D ring is inverted to form the IX isomer of protoporphyrin, which corresponds to the III isomer
of uroporphyrinogen and coproporphyrinogen. Siroheme is not a true porphyrin but rather is an isobacteriochlorin, since
its B and C rings have methyl groups substituted on the A and B rings, which prevents full macrocycle desaturation.
Likewise, heme d1 is also not a porphyrin but is a dioxoisobacteriochlorin.
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ﬁrst comprehensive overview of tetrapyrrole synthesis in the 1964 monograph by
Lascelles in the Microbial and Molecular Biology Series edited by Bernard Davis (30).
Initially, investigators interchangeably employed eukaryotic and prokaryotic sources of
material in their studies, believing that the pathway was conserved among all organ-
isms. Pathway intermediates were guessed, in part, from the excreted porphyrin and
porphyrin precursors found in human clinical samples and in microbial cultures. The
assumption of a universally conserved pathway, as described below, was inaccurate
and over the years has occasionally led to considerable confusion. Interestingly, data
that suggested alternative pathways to heme were reported even in the 1950s (31), but
they were routinely ignored or explained as experimental artifacts. Nevertheless, by the
early 1960s, most of the steps in the classical heme biosynthesis pathway were known,
although there were signiﬁcant voids, since none of the enzymes had been puriﬁed and
characterized and a few were yet to be identiﬁed. It was apparent that microorganisms
possessing the ability to synthesize hemoproteins had multiple and diverse mecha-
nisms to regulate the synthesis of their tetrapyrrole compounds (30). In particular, the
fact that oxygen played a signiﬁcant role in regulation was known and had been
studied in a variety of organisms, with Saccharomyces cerevisiae and Rhodobacter
sphaeroides being the most extensively examined. What was not appreciated at that
time was the diversity in pathway enzymes that had evolved to cope with the need
for oxygen-dependent and oxygen-independent mechanisms for two steps in the
pathway.
Multiple reviews of eukaryotic heme synthesis have been reported in the past
decade (13, 14, 32–34), but there is no comprehensive and current review of prokary-
otic heme synthesis. Short reviews within otherwise focused manuscripts can be found
(35–39), and there is an excellent review of tetrapyrrole biosynthesis in Rhodobacter
capsulatus (40). The last broad-scope genome-based review of prokaryotic heme syn-
thesis was reported over a dozen years ago by O’Brian and Thony-Meyer (41). This,
along with a parallel review on whole-microbial-genome analysis (39), began to chal-
lenge the dogmatic view of a conserved pathway model, when it was found that even
among a modest number of prokaryotic genomes (69 genomes), there were missing
genes for essential pathway steps in most bacteria, and no heme-synthesizing archaea
possessed an intact pathway.
More recent studies have revealed that there are multiple pathways for heme
synthesis in prokaryotes (11, 35, 42, 43), and in only limited instances does one ﬁnd a
set of enzymes in bacteria that closely resembles those of the so-called classic pathway
found in metazoans. It is now known that some archaea and sulfate-reducing bacteria
synthesize siroheme and then convert it to protoheme (11, 42), Gram-positive heme-
synthesizing bacteria go through a set of enzymes that utilize a coproporphyrin
intermediate (35, 43–45), and Gram-negative bacteria have a set of enzymes that go
through a protoporphyrin intermediate (35). These various pathways to heme in
prokaryotes have acquired a variety of common names, such as primitive (46), alternate
(11), transitional (43), and classic. While this nomenclature may ﬁnd favor among those
closely involved in the study of these pathways, it is not particularly obvious or
transparent to the general audience. Here we have chosen to name the pathway
branches based upon compounds unique to each one. Thus, the primitive, or alterna-
tive, pathway becomes the siroheme-dependent branch, the transitional pathway is
named the coproporphyrin-dependent (CPD) branch, and the classic pathway is named
the protoporphyrin-dependent (PPD) branch.
This review of protoheme biosynthesis is presented loosely in an evolutionarily
based manner rather than a historical fashion. The core tetrapyrrole synthesis “trunk” of
the tree is ﬁrst, followed by the siroheme branch, then the coproporphyrin-based
branch, and ﬁnally the protoporphyrin-based branch. With the discovery of the
coproporphyrin- and protoporphyrin-dependent branches, we have employed new
nomenclature for the annotation of the pathway genes/proteins to eliminate the
confusion created by overlapping nomenclature. Our newly proposed nomenclature,
Prokaryotic Heme Biosynthesis Microbiology and Molecular Biology Reviews
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along with the old nomenclature, is given in Table 1 and is based upon enzyme activity
rather than the pathway name and number/letter.
THE TETRAPYRROLE BIOSYNTHESIS PATHWAY COMMON CORE
5-Aminolevulinate Synthesis: Two Pathways to ALA
In nature, there are two independent, unrelated, biosynthetic routes for the forma-
tion of ALA. The ﬁrst of these routes to be discovered was the so-called “Shemin” or “C4”
pathway, which involves the condensation of succinyl coenzyme A (CoA) and glycine by
5-aminolevulinic acid synthase (AlaS) (Fig. 3). This reaction is used by metazoans, fungi,
and the alphaproteobacteria, with few exceptions, and for many years, this was thought
to be the sole mechanism for the production of ALA, even though AlaS activity in plants
and some bacteria had never been detected. It was 2 decades before an alternate route
to ALA was discovered. This route, which is likely the evolutionarily older process,
termed the “C5 pathway,” utilizes the C5 skeleton of a tRNA-bound glutamate to
generate ALA in a two-step reaction. This route is found in plants, archaea, and most
bacteria. The initial substrate, glutamyl-tRNA, is synthesized by glutamyl-tRNA synthe-
tase (GluRS), is utilized in both protein and tetrapyrrole biosynthesis, and is one of the
few examples of a charged tRNA species being used for something other than trans-
lation. Glutamyl-RNA is converted into the labile glutamate-1-semialdehyde (GSA)
intermediate by glutamyl-tRNA reductase (GtrR) and is then converted into ALA by
glutamate-1-semialdehyde-2,1-aminomutase (GsaM) (Fig. 4 and 5). Only in very rare
instances have both pathways for ALA formation been found in a single organism, such as
Euglena gracilis (14, 33, 47–49) and Chromobacterium violaceum (http://www.theseed.org/
SubsystemStories/Porphyrin,_Heme,_and_Siroheme_Biosynthesis/story.pdf).
The Shemin pathway for ALA biosynthesis: 5-aminolevulinic acid synthase. AlaS
catalyzes the condensation of succinyl-CoA and glycine to ALA with the release of CO2
and coenzyme A. In 1945, Shemin and Rittenberg reported the incorporation of
nitrogen atoms from glycine into heme (50). Subsequently, in the 1950s and 1960s, the
groups of Shemin and Neuberger identiﬁed succinyl-CoA as the other source of carbon
atoms in heme, with ALA being identiﬁed as the ﬁrst committed precursor molecule for
heme formation and AlaS being identiﬁed as the ﬁrst enzyme of heme biosynthesis
(51–56). AlaS is a homodimeric protein and belongs to the -oxoamine synthase class
of pyridoxal-5=-phosphate (PLP)-dependent enzymes, which catalyze the condensation
of an acid-CoA thioester and small amino acids with the concomitant decarboxylation of
the amino acid (57, 58) (Fig. 3). However, the cleavage of two -carbon bonds during
the AlaS reaction is unusual for PLP-dependent enzymes. The reaction mechanism has
been elucidated through the employment of region-speciﬁc labeled substrates coupled
with detailed kinetic studies using high-resolution stopped-ﬂow techniques with the
knowledge of the only currently solved AlaS crystal structure, that of the R. capsulatus
TABLE 1 Names and abbreviations for bacterial heme synthesis enzymes
Enzyme Old abbreviation(s) New abbreviation
ALA synthase HemA AlaS
Glu-tRNA reductase HemA/GtrA GtrR
GSA mutase HemL/GSAM GsaM
PBG synthase HemB/ALAD/PBGS PbgS
HMB synthase HemC/HMBS/PBGD HmbS
URO synthase HemD/UROS UroS
URO decarboxylase HemE/UROD UroD
Coproporphyrinogen decarboxylase HemF/CPOX CgdC
Coproporphyrinogen dehydrogenase HemN/HemZ/CPDH CgdH
Protoporphyrinogen dehydrogenase HemG PgdH1
Protoporphyrinogen dehydrogenase HemJ PgdH2
Protoporphyrinogen oxidase HemY PgoX
Protoporphyrin ferrochelatase HemH PpfC
Coproporphyrin ferrochelatase HemH/HemZ CpfC
Coproporphyrinogen oxidase HemY CgoX
Coproheme decarboxylase HemQ ChdC
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enzyme (49, 59–63) (Fig. 3A). Initially, an active-site lysine covalently binds the PLP
cofactor to form the internal aldimine (Fig. 3B). The external aldimine is formed via a
Schiff base to the ﬁrst substrate, glycine, and the PLP cofactor. Stereospeciﬁc abstrac-
tion of the pro-R-hydrogen as a proton from the PLP-bound glycine generates quinon-
oid intermediate I. Subsequently, the electrophilic carbonyl group of succinyl-CoA
binds to the -carbon of glycine with the formation of the 2-amino-3-ketoadipate as an
intermediate. The quinonoid intermediate II is formed after the release of coenzyme A
FIG 3 5-Aminolevulinic acid synthase (AlaS). (A) Crystal structure of AlaS from R. capsulatus. (Left) AlaS is a homodimeric protein in which
each monomer (shown in color or gray) consists of three domains (red, green, and blue). (Right) In the active site of the enzyme, the PLP
cofactor is covalently attached as a Schiff base to a conserved lysine residue. (Adapted from reference 14.) (B) Proposed reaction
mechanism by which AlaS catalyzes the PLP-dependent condensation of glycine and succinyl-CoA to form ALA (see the text for a detailed
explanation). (Adapted from reference 61.)
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from the tetrahedral intermediate and the decarboxylation of the resultant -amino-
-ketoadipate aldimine. The AlaS-ALA-aldimine is formed via the protonation of the
quinonoid, and ALA is ﬁnally released from the enzyme as the product after the
completion of this cycle (49, 59–62).
The C5 pathway of ALA biosynthesis: glutamyl-tRNA reductase and glutamate-
1-semialdhyde-2,1-aminomutase. In 1973, a second pathway for ALA formation from
the C5 skeleton of glutamate was discovered by Beale et al. in cucumber cotyledons (64,
65). Subsequently, the conversion of glutamate via GSA to ALA was demonstrated, and
the relevant enzymes from barley were isolated and biochemically characterized (66,
67). As a result of these efforts, glutamyl-tRNA was identiﬁed as the starting molecule
of the pathway (68). The C5 pathway enzymes GtrR and GsaM were subsequently
puriﬁed from multiple bacterial, archaeal, and plant sources (48).
For many years, the crystal structure of Methanopyrus kandleri GtrR was the only one
available for this enzyme (69) (Fig. 4A). Recently, a second structure representing
Arabidopsis thaliana GluTR has become available (70). GtrR is a highly asymmetric,
V-shaped, dimeric enzyme composed of catalytic (domain I), nucleotide-binding fold-
containing (domain II), and dimerization (domain III) domains. These three domains are
arranged along a curved spinal helix (69). This structure allows the necessary movement
of NADPH-binding domain II toward active-site domain I during catalysis and the
formation of a complex with GsaM to permit the metabolic channeling of solvent-
sensitive GSA. During GtrR catalysis, an active-site cysteine residue acts as a nucleophile
to attack the tRNA-activated -carboxyl group of glutamate with the formation of an
enzyme-bound thioester and the release of tRNAGlu (71, 72) (Fig. 4B). Hydride transfer
from NADPH to the thioester leads to GSA formation and its release (73). Glutamyl-tRNA
is recognized by GtrR from the overall shape of the tRNA molecule rather than by
speciﬁc single nucleotides and the attached glutamate (74).
Crystal structures of various GsaM enzymes (i.e., Synechococcus, Thermosynechococ-
FIG 4 Glutamyl-tRNA reductase (GtrR). (A, left) Crystal structure of M. kandleri GtrR showing the unusual V-shaped form of the
dimeric enzyme. (Right) In the active site of GluTR, C-48 is ideally positioned to attack the -carboxyl group of the substrate.
(Adapted from reference 14.) (B) Proposed reaction mechanism by which GtrR catalyzes the NADPH-dependent reduction of
glutamyl-tRNA to glutamate-1-semialdehyde (see the text for a detailed explanation).
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cus elongatus, Bacillus subtilis, Bacillus anthracis, Thermus thermophilus, Aeropyrum
pernix, and Yersinia pestis) have been solved (75–77). GsaM is a functional dimer, with
large central domains harboring the active sites close to the dimer surface (75–77) (Fig.
5A). The subunits are asymmetric and act cooperatively during catalysis through a
process involving structural signaling between them (78, 79). GsaM is part of the
-family of PLP-dependent enzymes and has interesting structural similarity to AlaS.
This had led to speculation that GsaM is an evolutionary precursor of AlaS (77). In
contrast to typical aminotransferases, GsaM is an aminomutase that uses GSA as the
sole substrate, transferring the amino group intramolecularly. During catalysis, a com-
plex is ﬁrst formed between the pyridoxamine-5=-phosphate (PMP) form of GsaM and
GSA, with the subsequent generation of the ketamine-5 form (Fig. 5B). Double-bond
shifts lead to the formation of the external aldimine between PLP and 5=-diaminovalerate
(DAVA). Next, the internal aldimine between an active-site lysine and PLP is formed with
the release and reorientation of DAVA (80, 81). An active-site gating loop of GsaM
prevents the escape of DAVA (82). A second external aldimine between DAVA and PMP
is formed, followed by the formation of the ketamine-4 form between PMP and ALA.
Finally, the PMP of GsaM is regenerated with the release of ALA (83–86). Structures
revealed that the GsaM and GtrR enzymes form a stable complex for channeling of the
labile GSA intermediate (87, 88). In this complex, GsaM sits in the middle of the
V-shaped GtrR dimer within close proximity of the GtrR active-site exit and the entrance
to the GsaM active site (69, 70).
FIG 5 Glutamate-1-semialdehyde-2,1-aminomutase (GsaM). (A, left) Crystal structure of T. elongatus GsaM.
(Right) In the active site of Synechococcus GsaM, the inhibitor gabaculine was observed to bind covalently to
the PLP cofactor (m-carboxyphenylpyridoxalamine [mCPP]). (Adapted from reference 14.) (B) Depending on
the initial form of the pyridoxal phosphate cofactor, GsaM is able to convert GSA into ALA via either DAVA
or DOVA (4,5-dioxovalerate) (see the text for a detailed explanation). Kinetic and other biochemical data
suggested that formation via DAVA is used by the enzyme. (Adapted from reference 77.)
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Synthesis of a Monopyrrole, Porphobilinogen Synthase
Porphobilinogen synthase (PbgS) catalyzes the asymmetric condensation of two
ALA molecules to the monopyrrole porphobilinogen. There are two ALA-binding sites,
the so-called A and P sites, corresponding to the ALA that contributes to the acetate
and propionate portions of PBG, respectively (Fig. 6). The P-site ALA forms a Schiff base
with a conserved lysine residue (K247 in Escherichia coli). Features of the A site may
differ among PbgS enzymes from different organisms depending on the metal require-
FIG 6 Porphobilinogen synthase (PbgS). (A, left) Crystal structure of P. aeruginosa PbgS showing the octameric assembly of the
protein representing a tetramer of homodimers. (Top right) In the active site of P. aeruginosa PbgS, two molecules of
the substrate analog 5-ﬂuorolevulinic acid (5F-LA) were observed to bind covalently to the enzyme through Schiff bases, with
the catalytically essential lysine residues supporting a double-Schiff-base mechanism. (Bottom right) The antibiotic alaremycin
was also observed to bind covalently to the enzyme through a Schiff base with the P-site lysine. (Adapted from reference 14.)
(B) Proposed reaction mechanism by which PbgS catalyzes the asymmetric condensation of two ALA molecules to the pyrrole
porphobilinogen (see the text for a detailed explanation). (Adapted from reference 97.)
Dailey et al. Microbiology and Molecular Biology Reviews
March 2017 Volume 81 Issue 1 e00048-16 mmbr.asm.org 10
 o
n













ment. The enzyme is a homooctomer in both eukaryotes and prokaryotes (89–93) and
requires metal for activity (94). Three binding sites for divalent metals have been
described, but not all porphobilinogen synthase proteins have all three sites. Animals
and yeast have two Zn2-binding sites (ZnA and ZnB), but the plant enzyme binds
Mg2 in an MgA/MgB/MgC conﬁguration. Prokaryotes also have an MgC site, which is
allosteric. Most bacterial PbgSs contain either Zn2 or Mg2 in the active site, but the
R. capsulatus enzyme is metal independent (95). The introduction of cysteines in
positions of Mg2 PbgS normally found in the Zn2 enzymes is sufﬁcient to alter the
metal speciﬁcity from Mg2 to Zn2 (96, 97). The modiﬁed enzyme also acquires
sensitivity to lead and has a pH optimum that is 3.5 units lower than that of the wild
type, as is observed for the naturally occurring Zn2-containing enzyme. For Pseudomo-
nas aeruginosa PbgS, a series of mutant combinations intermediate between the two
types of enzymes was extensively characterized (97). These variants were similar to
naturally occurring PbgS enzymes from other organisms that vary in their dependence
on Zn2 or Mg2. Of the nine variants constructed, ﬁve have no known natural
equivalent, and four of these are inactive. Thus, a plausible evolutionary path of metal
dependence could be deduced.
Binding and kinetic studies indicate that Bradyrhizobium japonicum PbgS contains
four active-site Mg2 atoms per octamer and eight allosteric Mg2 ions (98). This
enzyme is also stimulated by the monovalent cation K (98, 99). The Mg2 enzyme
from P. aeruginosa contains only four allosteric ions per octamer, but activity is not
strictly metal dependent (93). The crystal structure of the P. aeruginosa enzyme shows
that it is composed of 4 asymmetric dimers. The monomers in each dimer differ by one
having a closed active-site pocket shielded from the solvent by a “lid” that is disordered
in the open active site (93). Mg2 is 14 Å away from the Schiff base lysine, which is too
far away to play a direct catalytic role. However, it has been suggested that the open
and closed forms of each monomer are governed by Mg2 binding (93). Unlike the P.
aeruginosa enzyme, E. coli PbgS is symmetric. Interestingly, crystal structures of P.
aeruginosa variants with cysteine substitutions show decreasing asymmetry with in-
creasing numbers of cysteines (97).
Although structural information on porphobilinogen synthases from many sources
shows that the predominant active form of the enzyme is a homooctamer, alternate
oligomeric states have been identiﬁed (89, 100–103). Jaffe (100) introduced the term
morpheein to describe this phenomenon. A morpheein is a homooligomeric protein
that exists in an equilibrium of functionally distinct, quaternary structural isoforms. The
morpheein isoforms of human PBGS are an octamer, a hexamer, and two different
dimers. The interconversion of the octamer to the hexamer involves dissociation to a
dimer. The hexamer isoform was initially recognized in a rare human PBGS allele,
whereby rearrangement of the N-terminal arm caused by an F12L substitution was
responsible for the oligomeric switch leading to a low-activity enzyme (89). The variant
N-terminal arm structures vary among the morpheeins, and the relationship between
the arm and the -barrel domain dictates the isoforms. An R240A mutation in PBGS that
affects this relationship stabilizes the hexamer, which can be converted to the octamer
in the presence of the substrate (103). The physiological relevance of these morpheeins
is apparent from a study of PBGS variants found in patients with the disease aminole-
vulinate dehydratase (ALAD) (now known as PBGS) porphyria (101). All eight known
porphyria-associated variants shifted the morpheein isoform from the octamer toward
the hexamer, which can explain the deﬁciency in these patients. Morpheein structures
have not been described for any bacterial PbgS enzyme, but interestingly, PbgS of R.
capsulatus is normally active as a hexamer and does not require any metal (95).
From Porphobilinogen to Tetrapyrrole
The transformation of the pyrrole building block, PBG, into the ﬁrst macrocyclic
intermediate, uroporphyrinogen III, requires the actions of two enzymes, hydroxy-
methylbilane synthase (HmbS) and uroporphyrinogen synthase (UroS). In bacteria,
these enzymes are encoded by hemC and hemD. The ﬁrst of these enzymes, HmbS, was
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initially termed porphobilinogen deaminase (PBGD), as the enzyme deaminates the
aminomethyl moiety of PBG and releases this as ammonia (104). The deaminated
pyrroles are then strung together to generate a linear tetrapyrrole, or bilane, which is
subsequently cyclized in a very speciﬁc manner by the proceeding enzyme, UroS, to
generate the type III isomer of uroporphyrinogen (104) (Fig. 7). In early studies
investigating the transformation of PBG into uroporphyrinogen III, researchers found
that the two enzymes tended to purify together, and hence, the latter enzyme was
referred to as the cosynthase. However, this enzyme is now more commonly referred
to as uroporphyrinogen III synthase (UroS). The two enzymes HmbS and UroS were
initially differentiated on the basis of their heat stability: HmbS is normally heat stable
at temperatures of up to 70°C, whereas UroS is heat labile at temperatures much
above 50°C. Thus, an extract containing the two enzymes would transform PBG into
uroporphyrinogen III, whereas a heat-treated extract would convert PBG into HMB,
which would then spontaneously cyclize into the type I isomer (Fig. 7). This established
that the two enzymes required for uroporphyrinogen III production acted separately. As
with the earlier enzymes in the pathway, much has been learned about HmbS and UroS
from human genetic disorders that cause porphyria, in these cases acute intermittent
porphyria and congenital erythropoietic porphyria, respectively (105).
Early work on these two enzymes was hampered by a lack of knowledge of the
reactions actually catalyzed by the two enzymes. In this respect, the product of HmbS
was unknown, and hence, the substrate for UroS was likewise a mystery. The problem
was solved by the application of nuclear magnetic resonance (NMR). By using puriﬁed
HmbS from R. sphaeroides, it was demonstrated that incubation of [11-13C]PBG gave
rise to a transient intermediate, with a half-life of about 5 min, which spontaneously
cyclized to give uroporphyrinogen I (106). However, in the presence of UroS, this
transient intermediate was rapidly converted into uroporphyrinogen III. The interme-
diate was initially called preuroporphyrinogen (106), and it did not take long before it
FIG 7 Transformation of porphobilinogen into uroporphyrinogen III. Four molecules of porphobilinogen are
deaminated and polymerized in an ordered sequential fashion (rings A to D) into a linear tetrapyrrole called
hydroxymethylbilane by the action of hydroxymethylbilane synthase. The unstable bilane is acted upon by the
enzyme uroporphyrinogen synthase, which inverts ring D and cyclizes the macrocycle to give the type III isomer
of uroporphyrinogen. In the absence of the enzyme, hydroxymethylbilane spontaneously cyclizes to give the type
I isomer.
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was shown to be HMB. This was unambiguously demonstrated by total chemical
synthesis of the compound, which was revealed to be the preferred substrate for UroS
(107). Aminomethyl bilane also acted as a substrate for the enzyme but was converted
by HmbS at a much lower rate (108–110). HmbS is evidently able to deaminate the
aminomethyl bilane and convert it to HMB (111). The identiﬁcation of HMB as the
product of HmbS and the substrate for UroS then permitted more detailed analyses of
the mechanism for the two enzymes.
Hydroxymethylbilane synthase. Considerable evidence suggested that HmbS must
form a covalent complex with its substrate during the pyrrole polymerization process,
but the amino acid residue involved in this attachment process was unknown. The
formation and identiﬁcation of enzyme-substrate complexes were shown by native
polyacrylamide gel electrophoresis of enzyme samples that had been incubated with
increasing stoichiometric quantities of PBG (112, 113). This revealed that the enzyme
ran as either a free enzyme or an enzyme with one, two, three, or four substrates
attached. These enzyme-substrate complexes were referred to as ES1, ES2, ES3, and ES4
(Fig. 8A). Around the same time, through the stoichiometric addition of either radio-
labeled ([3,5-14C]PBG) or heavy ([11-13C]PBG) isotopes, it was demonstrated that HMB
was synthesized in an ordered and sequential fashion, with the ﬁrst PBG ending up as
ring A, the second as ring B, the third as ring C, and the ﬁnal PBG as ring D within the
ﬁnal macrocycle (114, 115). Together, all of this evidence indicated that the enzyme
forms HMB by forming a growing polypyrrole chain attached presumably to the active
site (Fig. 8A).
The advent of recombinant-DNA technology played a key role in the identiﬁcation
of the key active-site residues involved in forming the growing bilane chain attached
to the enzyme. The discovery, isolation, and sequencing of the E. coli hemC gene
allowed the enzyme to be overproduced, making the protein much more readily
available (116, 117). Most HmbSs have a molecular mass of around 35 kDa and are
monomeric. Two independent pieces of research established that the key active-site
residue to which the ﬁrst PBG unit attaches was, in fact, a dipyrromethane cofactor
(118–120) (Fig. 8A). This was deduced from several pieces of evidence. An elegant NMR
approach, whereby [11-13C]PBG was added to a large amount of the enzyme, resulted
in an NMR spectrum that suggested that the ﬁrst PBG unit had formed a methylene
bridge with the enzyme. Moreover, it was also observed that the free enzyme, to which
no PBG had been added, formed signiﬁcant quantities of porphyrin when treated with
a strong acid. Both of these pieces of evidence suggested that some pyrrole species was
already attached to the enzyme. Finally, treatment of the free enzyme with Ehrlich’s
reagent gave a reaction consistent with the presence of a dipyrrole. The ES1 substrate
complex reacted with Ehrlich’s reagent to give a spectrum typical of a tripyrrole, while
the ES2 substrate complex gave a reaction typical of a linear tetrapyrrole.
Further evidence of the presence of a dipyrromethane cofactor came from the
radioactive incorporation of ALA into the enzyme during the production of the recom-
binant enzyme in E. coli (121). In this case, a hemA strain of E. coli was used to
overproduce the enzyme and was grown in the presence of added exogenous
[5-14C]ALA. This resulted in the incorporation of the label into the enzyme, a label that
was not turned over when the puriﬁed enzyme was incubated with the unlabeled
substrate. This indicated that the ALA was converted into PBG, which was subsequently
incorporated into the active site of the enzyme. It had also been noted previously that
a hemB (PbgS)-deﬁcient strain of E. coli not only was deﬁcient in PbgS activity but also
lacked HmbS activity, presumably because the strain was unable to provide the PBG for
cofactor assembly (122).
NMR was again employed to determine how the dipyrromethane cofactor was
attached to the enzyme. By the incorporation of either [5-13C]ALA or [11-13C]PBG into
the enzyme, the resulting spectra conﬁrmed not only the presence of the dipyrrometh-
ane cofactor but also that the cofactor was attached to the sulfur atom of a cysteine
residue (123, 124). At that time, there were only comparatively few sequences of HmbS
available, and when aligned, these sequences highlighted the presence of two con-
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served cysteine groups within the protein. Site-directed mutagenesis then identiﬁed
that cysteine 242 of the E. coli enzyme was the residue responsible for the binding of
the dipyrromethane cofactor. The presence of the cofactor has since been conﬁrmed in
a broad range of HMBSs that have been studied.
The next question to be addressed was related to how the cofactor was assembled
and inserted into the enzyme. In fact, it soon became apparent that the enzyme was
able to generate its own cofactor. This was demonstrated by showing that the
apoenzyme, an enzyme without any cofactor, generated either by isolating the enzyme
FIG 8 Mechanism and structure of hydroxymethylbilane synthase (HmbS). (A) Mechanism of action of HmbS. HmbS contains a
dipyrromethane cofactor, which is attached to an active-site cysteine residue and constitutes the holoenzyme form. The two rings of the
cofactor are termed C1 and C2. During the polymerization process, the ﬁrst substrate PBG molecule, ring A of the ﬁnal product, undergoes
deamination to generate an azafulvene species. This is then attached to the C2 ring of the cofactor to generate the ES1 substrate complex.
This process is then repeated three more times to generate the ES2, ES3, and ES4 substrate complexes. The ES4 complex then undergoes
hydrolysis between the C2 cofactor ring and ring A of the ﬁnal product to generate the holoenzyme and the hydroxymethylbilane
product. The acetate and propionate side chains are designated A and P, respectively. (B) Structure of E. coli HmbS shown in cartoon
format, colored according to secondary structure. The 312 amino acid residues of the enzyme are folded into three /-domains with a
large active-site cavity formed in the space between the three domains. The dipyrromethane cofactor is seen attached to C242 with a key
catalytic residue, D84, located just below the two N atoms of the dipyrromethane.
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from an E. coli gtrR or pbgS strain or by treating the holoenzyme with 1 M HCl, could
have its activity restored by incubating it with PBG on ice (121, 123). The apoenzyme
is able to deaminate PBG to allow the attachment of the ﬁrst pyrrole ring of the cofactor
to the enzyme, a process that is repeated for the incorporation of the second PBG-
derived pyrrole unit for the completion of the cofactor. Subsequently, it was shown that
hydroxymethylbilane was incorporated more quickly than PBG to give an active
enzyme, presumably allowing the direct formation of an ES2 complex (125, 126).
The recombinant production of E. coli HmbS allowed the enzyme to be crystallized,
and it was the ﬁrst enzyme of tetrapyrrole biosynthesis to have its structure determined
by X-ray crystallography (116, 127). This structure revealed that the protein was
composed of three domains, with the dipyrromethane cofactor being attached to
domain 3 and with the majority of the active site being formed within a cleft between
domains 1 and 2 (128, 129) (Fig. 8B). The cofactor was observed to be positioned just
above an aspartic acid (D84) residue, which appears to be the main catalytic group,
although the active site is lined with arginine residues not only to help hold the
cofactor but also to accommodate the growing polypyrrole chain via the negatively
charged carboxylates of the pyrrole units (130, 131). The role of these residues in
catalysis and substrate binding was conﬁrmed by site-directed mutagenesis. Since then,
the structures of a number of HmbSs have been determined, including those of
Arabidopsis, human, and Bacillus megaterium, revealing similar overall topologies (132–
135). Interestingly, no one has been able to grow crystals of the enzyme in the presence
of a substrate, so it is not known how the growing polypyrrole product is held within
the active site of the enzyme or how the domains of the enzyme move during the
catalytic process. Conformational change is known to take place during the reaction,
and indeed, computation molecular analysis suggests that the structure of the enzyme
becomes progressively less compact during the catalytic reaction (121, 136). Moreover,
those studies also suggest that the cofactor moves toward the second domain to
generate more space for the growing product (137).
Collectively, all of these data have allowed an overarching mechanism for the
enzyme to be developed (121) (Fig. 8A). The holoenzyme binds the ﬁrst substrate PBG
unit in the active site, in close proximity to the dipyrromethane cofactor with the C-11
position of PBG above the catalytic aspartate acid residue, which participates in
acid-base catalysis (Fig. 8B). This promotes the deamination of the PBG to generate an
azafulvene on C-11 (Fig. 8A), which is then able to react with the free alpha position of
the cofactor. In doing so, the cofactor is extended to a tripyrrole, generating the ES1
substrate complex. This process is then repeated three more times, with incoming PBG
substrates undergoing deamination and polymerization onto the free alpha position of
the growing polypyrrole. These processes generate the ES2, ES3, and ES4 complexes,
which represent tetra-, penta-, and hexapyrrole species at the active site of the enzyme.
Once the ES4 complex has formed, the bond between ring A of the product and the
dipyrromethane cofactor is hydrolyzed to generate the hydroxymethylbilane (Fig. 8A).
It is likely that the same aspartate residue (D84 in the E. coli enzyme) is involved in the
hydrolysis process, although there is also evidence to suggest that another conserved
residue, D46, may also play a role in the disassembly of the complex (138).
Uroporphyrinogen synthase. In contrast to the relatively stable and abundant
HmbS enzyme, UroS has proven to be a difﬁcult enzyme to study because it is very
labile to proteolysis and temperature. UroS is a much more active enzyme than its
predecessor in the pathway, and hence, the quantity of UroS within the cell is
signiﬁcantly smaller than that of HmbS. Moreover, the assay employed at that time for
UroS was not straightforward, making the detection of the enzyme rather difﬁcult.
However, several things came together to help permit more detailed studies of this
enzyme. The advent of recombinant-DNA technology allowed the enzyme to be
produced in much larger quantities (139, 140), and the development of a ﬂuorescence-
based assay (141) coupled with more accurate high-performance liquid chromatogra-
phy (HPLC) analysis to separate the type I and III isomers made the assays much more
rapid and accurate (142). Consequently, after the initial laborious methods to isolate the
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ﬁrst puriﬁed UroS enzyme from human blood (143), quite a few UroSs from a variety of
organisms were subsequently puriﬁed as a consequence of recombinant-DNA ap-
proaches (144–147). UroSs are generally monomeric species with molecular masses of
around 30 kDa.
UroS undertakes quite a remarkable reaction. Not only does it cyclize its bilane
substrate, it also inverts the D ring to generate the type III isomer (Fig. 7). A simple
cyclization alone would generate the type I isomer (Fig. 7). However, nature has opted
for the type III isomer as the template upon which all the major biologically modiﬁed
tetrapyrroles are based. Of the four possible isomers, the type III isomer is the only
unsymmetrical variant, and it could be that nature has selected this lack of symmetry
as a molecular handle or reference point for further modiﬁcation of the molecule (148).
However, the type III isomer is also the most abundant isomer formed when PBG is left
under acidic (nonenzymatic) conditions, suggesting that this variant would have been
more prevalent within a prebiotic soup and therefore more available for biological
selection (149).
The type III isomer means that the order of the acetate and propionate side chains
of ring D is inverted with respect to rings A, B, and C. This ability to invert ring D of the
bilane and enforce ring closure obviously makes the reaction mechanistically interest-
ing. The favored mechanism for UroS was proposed by Mathewson and Corwin over 50
years ago and involves a cyclic spiro intermediate (150). Overall, the reaction involves
the loss of the hydroxyl group from the substrate HMB to allow it to form the spiro
intermediate by generating a bond between the C-1 and C-16 positions of the substrate
(Fig. 9A). This involves breaking the bond between the C-15 methylene and ring D to
generate an azafulvene in ring C, which can then react with the free alpha position on
ring D to generate the type III isomer of uroporphyrinogen. Evidence for this mecha-
nism comes from studies using a spirolactam analog, which acts as a strong compet-
itive inhibitor, suggesting that the molecule resembles the intermediate (151–153). The
chemical synthesis of this spirolactam has actually generated two enantiomers, and
X-ray analysis revealed that it is the R conﬁguration that acts as the inhibitor (154, 155).
Previous work with HMB analogs had shown that the enzyme inverts the terminal D
ring (108–110). Thus, given a bilane with the D ring already inverted, the enzyme forms
the type I isomer.
Although uroS sequences from a broad range of sources have been determined, a
comparison of the encoded proteins reveals only a relatively low level of conservation
when their sequences are aligned (156). Attempts to identify key catalytic groups
associated with the activity of the enzyme identiﬁed only a tyrosine residue whose
mutagenesis reduced, but did not abolish, activity (157). All this suggested that there
was no key amino acid residue involved in the reaction mechanism. Signiﬁcant progress
in the understanding of the function of UroS was next to come from the crystal
structure of the human enzyme (158). The human enzyme was the ﬁrst to have its
structure solved, and this structure revealed that the protein is bilobed, composed of
two domains that are separated by a two-stranded -sheet. This arrangement gener-
ates a large active site that is easily able to accommodate the substrate (Fig. 9B). Again,
mutagenesis of potential catalytic residues within the active site did not identify any
essential amino acid. A follow-up structural study, this time with Thermus thermophilus
UroS crystallized in the presence of uroporphyrinogen III, revealed that the protein is
able to adopt a range of different conformations (159). Signiﬁcantly, however, the
product was observed to bind between the two domains and is held in place through
an intricate series of hydrogen bonds (Fig. 9B). In this product complex, rings A and B
are held more tightly than are rings C and D. In contrast, a density functional analysis
of the reaction suggested that the D ring of HMB binds to the enzyme in a conforma-
tion that protects it from reacting with ring A and thereby prevents the formation of the
type I isomer as a product (160). Interestingly, however, the crystal structure of the T.
thermophilus enzyme with uroporphyrinogen III identiﬁed a conserved tyrosine residue
that may help in the elimination of the hydroxyl group from HMB (159). A crystal
structure of the Pseudomonas syringae enzyme has also been determined and shows a
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similar overall topology but a conformation different from those of both the human
and T. thermophilus enzymes (161). Collectively, all this information conﬁrms a mech-
anism involving a spiro intermediate, as outlined in Fig. 9A.
SIROHEME TO PROTOHEME/HEME d1 BRANCH
Discovery of a Novel Alternative Pathway
Serendipity often plays a role in scientiﬁc discovery, and so it was with the ﬁnding
of an alternative route for the biosynthesis of heme. As part of a comprehensive study
of Desulfovibrio vulgaris cytochrome c3, a small tetraheme protein that acts as an
electron carrier for the hydrogenase, Akutsu and colleagues were trying to correlate a
number of microscopic redox potentials with the hemes present within the protein
(162). To achieve this, they labeled the protein with a number of deuterated amino
acids, including phenylalanine, tyrosine, histidine, and methionine. To their surprise,
they found that when the protein was isolated from a strain that had been fed
methionine, deuterated in the methyl group, the deuterium was incorporated not only
into the protein but also into two of the methyl groups of the hemes. More speciﬁcally,
by NMR, those researchers observed that the hemes had a reduced signal from the
methyl groups attached to C-2 and C-7 and concluded that these methyl groups likely
FIG 9 Mechanism and structure of uroporphyrinogen III synthase (UroS). (A) Mechanism of action of UroS. The transformation of
hydroxymethylbilane into uroporphyrinogen III is thought to proceed via a spiro intermediate, which is itself formed from an azafulvene
intermediate generated from the loss of the hydroxyl group. Rearrangement of the spiro intermediate is then able to produce the type
III isomer of uroporphyrinogen. The acetate and propionate side chains are designated A and P, respectively. (B) Structure of UroS. The
structure of uroporphyrinogen III synthase from T. thermophilus, together with its product uroporphyrinogen III, is shown in cartoon
format. The 252 amino acid residues of the enzyme are folded into two /-domains with a large active site formed at their juncture. There
are a few highly conserved amino acid residues found in the active site, suggesting that the binding of the substrate in the correct
orientation promotes the chemistry outlined in panel A.
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had been derived from SAM rather from the decarboxylation of the acetic acid side
chains of uroporphyrinogen III (162).
The classic heme biosynthetic pathway does not involve the methylation of the
tetrapyrrole framework, as the four methyl groups within the ﬁnal (heme) product
result from the decarboxylation of the acetic acid side chains of uroporphyrinogen III.
In contrast, the biosyntheses of siroheme (163, 164) and vitamin B12 (165–167) involve
the SAM-dependent methylation of the tetrapyrrole framework at positions C-2 and
C-7. This is achieved by the action of an enzyme called S-adenosyl-L-methionine
uroporphyrinogen III methyltransferase (SUMT), which speciﬁcally methylates uropor-
phyrinogen III at positions C-2 and C-7 in a SAM-dependent fashion to generate
precorrin-2, or dihydrosirohydrochlorin (166, 168) (Fig. 10). Precorrin-2 is a known
intermediate in the biosynthesis of siroheme (163, 169, 170), cobalamin (165, 171),
coenzyme F430 (172), and heme d1 (173, 174) (Fig. 10). As many of these prosthetic
groups are made under anaerobic conditions and are thought to be more evolution-
arily ancient than heme, it has been postulated that this alternative heme biosynthetic
pathway may represent a “primitive” pathway for porphyrin metabolism.
This radically different idea broke all dogma concerning the biosynthesis of heme.
It was thought at the time that heme was made via a speciﬁc set of pathway
intermediates, and although there was some variation in the nature of the enzymes,
anaerobic or aerobic, that catalyzed the synthesis of the intermediate, the intermedi-
ates remained constant between anaerobic and aerobic biosynthesis of heme.
Identification of New Intermediates?
Having provided evidence that heme in D. vulgaris was likely made from precorrin-2,
Ishida and colleagues then attempted to dissect the pathway (46). Initially, that
research group supplemented the growth medium of D. vulgaris cultures with 5-ALA
and methionine-methyl-d3 and analyzed any deuterated compound-containing modi-
ﬁed tetrapyrroles that they found within the strain. The porphinoid compounds were
isolated from cells after lysis and esteriﬁcation to allow their extraction into organic
solvents in their methyl ester form. This approach resulted in the identiﬁcation of
deuterated coproporphyrin III, protoporphyrin IX, and a previously unknown hexac-
arboxylic acid. The latter was subsequently structurally identiﬁed as 12,18-
didecarboxysirohydrochlorin (oxidized 12,18-didecarboxyprecorrin-2). From this, those
authors predicted an alternative pathway for the biosynthesis of heme from uroporphy-
rinogen III (Fig. 11) (46). For this pathway, they made the assumption that the compounds
that they had isolated from D. vulgaris were likely oxidized as a result of the extraction-
and-esteriﬁcation process. Thus, they predicted that uroporphyrinogen III undergoes bis-
methylation by a SUMT-dependent uroporphyrinogen III methyltransferase at positions C-2
and C-7 to generate precorrin-2, followed by the decarboxylation of the acetic acid side
chains attached to C-12 and C-18, to give 12,18-didecarboxy-precorrin-2, which then
FIG 10 Transformation of uroporphyrinogen III (Uro’gen III) into precorrin-2, a key precursor in the biogenesis of heme d1,
vitamin B12, coenzyme F430, siroheme, and heme. Precorrin-2 is synthesized from uroporphyrinogen III by the action of the
enzyme uroporphyrinogen III methyltransferase, which adds two S-adenosylmethionine-derived methyl groups to C-2 and
C-7 of the macrocycle.
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undergoes elimination of the acetic acid side chains attached to C-2 and C-7, yielding
coproporphyrinogen III. It was suggested that coproporphyrinogen III is converted to heme
via the more familiar intermediates of the classic pathway; i.e., coproporphyrinogen III is
transformed into protoporphyrinogen IX, then protoporphyrin, and ﬁnally heme (46).
However, aspects of this proposed pathway remained intellectually unsatisfying, as the
route seemed rather laborious, effectively having three enzymes to cover the role played by
the uroporphyrinogen decarboxylase within the classic pathway.
Further evidence for the novel transformation of uroporphyrinogen III into copro-
porphyrinogen III was provided by enzymatic assays using partially puriﬁed D. vulgaris
cell lysates (46). Incubation of uroporphyrinogen III with SAM and a D. vulgaris DEAE
low-salt elution fraction yielded precorrin-2, which was isolated and characterized as its
oxidized octamethyl ester. Incubation of precorrin-2, generated as described above,
with a DEAE-eluted medium-salt cell fraction then yielded a mixture of 12/18-
monodecarboxysirohydrochlorin and 12,18-didecarboxysirohydrochlorin (46). Finally,
when uroporphyrinogen III and SAM were incubated with the DEAE-eluted low-salt,
medium-salt, and high-salt fractions, coproporphyrin III was identiﬁed as its tetramethyl
ester (46). Although these enzyme activities were observed, the actual proteins were
not puriﬁed to homogeneity and therefore were not formally identiﬁed or character-
ized. Similarly, as the products of the reactions were identiﬁed only after isolation as
their oxidized esters, the exact nature of the enzymatic transformation was not deter-
mined with absolute certainty.
Siroheme as a Precursor to Heme d1 and Protoheme
With the discovery of this novel alternative pathway for the biosynthesis of heme,
it was suggested that perhaps this represented a more widespread and general, but
previously undetected, route for porphyrin formation. However, this idea was quickly
dispelled when it was shown that no radioactivity from 14C-labeled methyl-L-methionine
was incorporated into heme when added to cultures of Chlorobium vibrioforme (175). In a
FIG 11 Proposed alternative heme biosynthetic pathway. Initially, it was thought that the alternative heme pathway involved the
decarboxylation of precorrin-2 to give a didecarboxy compound, which then underwent a loss of the acetic acid side chains on rings A
and B to give coproporphyrinogen III. The latter could then be converted into heme via the classic pathway.
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similar vein, heme was found to still be produced when a Salmonella enterica ΔcysG strain,
a strain that is deﬁcient in the ability to make precorrin-2, was grown anaerobically (175).
CysG, in fact, is a multifunctional protein that not only houses the SAM-dependent
methyltransferase activity required to make precorrin-2 but also contains precorrin-2 de-
hydrogenase and sirohydrochlorin ferrochelatase activities and is therefore able to trans-
form uroporphyrinogen III into siroheme (163, 164, 169, 170).
The alternative heme pathway was therefore viewed very much as an evolutionary
remnant from an anaerobic world, representing a primitive pathway that would likely
be found in only a limited group of modern-day bacteria (46). In this respect, the
alternative pathway was envisaged as an ancient route that had been superseded by
the classic pathway, which became universally adopted in the eukaryotic world. How-
ever, increasing amounts of genome sequencing data started to reveal some interest-
ing insights into heme biosynthesis. In particular, most archaeal genomes were found
to be missing orthologs of hemE, hemF or hemN, hemG or hemY, and hemH even though
these genomes also encoded a number of hemoproteins, highlighting the fact that
they must be able to make heme through some alternative process (176). A similar
observation was also made for the genomes of sulfate-reducing bacteria, including that
of D. vulgaris (177). It was therefore proposed that heme-requiring archaea may make
heme by the alternative heme pathway ﬁrst put forward by Ishida and colleagues (176).
This idea proved to be correct, as when non-covalently bound heme was extracted
from cell lysates of Methanosarcina barkeri that had been grown on medium containing
L-(methyl-d3)methionine and analyzed by matrix-assisted laser desorption ionization
(MALDI) mass spectrometry, the data clearly showed that a signiﬁcant proportion of the
deuterated label had been incorporated into heme (176). This ﬁnding is consistent with
the presence of the alternative heme biosynthetic pathway that had been observed by
Ishida et al. (46).
Moreover, this result demonstrated that the alternative pathway was likely to be
much more widespread than previously thought, representing the major pathway for
heme synthesis within the archaeal kingdom of life (176). This prompted a more
detailed bioinformatic approach in order to help identify the proteins and enzymes
associated with the transformation of uroporphyrinogen III into heme within the
Archaea. This analysis involved searching 59 completely sequenced archaeal genomes
and looking for the clustering of genes associated with the known early genes of
tetrapyrrole synthesis (hemA, hemL, hemB, hemC, and hemD) (178). Interestingly, out of
the 59 genomes sequenced, 47 were found to have the early hemA, hemL, hemB, hemC,
and hemD genes required for the transformation of glutamyl-tRNA into uroporphyrino-
gen III. These genomes were also found to encode both a SUMT enzyme as well as a
precorrin-2 dehydrogenase, which together convert uroporphyrinogen III into sirohy-
drochlorin via precorrin-2 (178).
In 32 of the genomes studied, genes associated with the biosynthesis of heme d1
were also found (178). Heme d1 is a prosthetic group required by the cytochrome cd1
nitrite reductase, NirS, an enzyme that mediates the reduction of nitrite to nitric oxide
(179). NirS houses both a c-type cytochrome as well as heme d1. Technically, heme d1
is not actually a heme in that the macrocycle is not a porphyrin but rather is a
dioxoisobacteriochlorin. In this respect, the molecule is more similar to siroheme (also
an isobacteriochlorin) but differs in that the two propionate side chains attached to C-3
and C-8 are replaced by oxygen atoms, generating carbonyls at these positions. The
biosynthesis of heme d1 had not been elucidated, but gene clusters associated with the
construction of the prosthetic group had been identiﬁed (180, 181). The genes involved
in heme d1 synthesis were thought to include nirDL, nirE, nirF, nirG, nirH, nirJ, and nirN.
Furthermore, labeling studies established that the biosynthesis of heme d1 proceeded
via precorrin-2 (182), and consistent with this view, NirE was found to have a high
degree of similarity to SUMTs. Indeed, the activity of NirE was conﬁrmed by enzymo-
logical studies (173, 174), and a structure of the enzyme (178) revealed that it had an
overall topology similar to that of the SUMT associated with cobalamin biosynthesis
(168).
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Within the archaeal genomes, however, homologs of nirD, nirH, and nirJ were found
(178). Signiﬁcantly, the presence of these genes did not coincide with the presence of
NirS, the nitrite reductase, suggesting that these genes must have another function.
Often, these nir genes were found clustered with the hem genes (178). All of these data
were consistent with the nir-like genes being involved in the alternative heme biosyn-
thetic pathway. Interestingly, the nir-like genes were initially given the preﬁx ahb (for
archaeal heme biosynthesis), but subsequently, the acronym was changed to stand for
alternative heme biosynthesis, as these same nir-like genes were also found in the
sulfate-reducing bacteria and were also presumed to be associated with the alternative
heme pathway. A consensus of the genome data suggested that the following genes
were required for the transformation of uroporphyrinogen III into heme: the SUMT,
precorrin-2 dehydrogenase, nirD (ahbA), nirH (ahbB), nirJ1 (ahbC), and nirJ2 (ahbD)
genes (178). The next step was to try to assign a function to these gene products and
thus to elucidate the pathway.
Color Changes Highlight the Pathway
The major breakthrough in our understanding of the alternative heme biosynthesis
pathway and heme d1 synthesis came from experiments conducted with the nir cluster
of genes associated with heme d1 construction (11). When E. coli extracts containing
recombinant Paracoccus denitrificans NirDL, NirG, and NirH were incubated with siro-
hydrochlorin, a signiﬁcant color change was observed. No such color change was
observed when the puriﬁed proteins were incubated with sirohydrochlorin. The reac-
tion product was extracted as its free acid, no esteriﬁcation was involved, and the
compound was analyzed initially by liquid chromatography-mass spectrometry (LCMS).
What was remarkable was that the product had a mass consistent with that of
didecarboxysiroheme rather than didecarboxysirohydrochlorin (11). What had hap-
pened was that adventitious iron, present in the crude cell lysate, was chelated
nonenzymatically into sirohydrochlorin to give siroheme. It was siroheme that then
acted as a substrate for NirDL, NirG, and NirH, which catalyzed the decarboxylation
of the acetic acid side chains on C-12 and C-18 of siroheme to give 12,18-
didecarboxysiroheme (Fig. 12). This was conﬁrmed when siroheme was incubated
with puriﬁed NirDL, NirG, and NirH and was converted into the didecarboxy form.
Incubation of puriﬁed NirDL, NirG, and NirH with either sirohydrochlorin or
precorrin-2 did not give a product. The structure of 12,18-didecarboxysiroheme was
conﬁrmed by NMR (11).
NirDL, NirG, and NirH are proteins that share a degree of similarity with each other
and also display sequence similarity with the Lrp/AsnC family of transcriptional regu-
lators. NirD and NirL proteins are found as separate proteins in some organisms such
as P. aeruginosa but are fused together in bacteria such as P. denitrificans. There is also
similarity between NirDL, NirG, and NirH and the AhbA/B proteins found in the Archaea
and sulfate-reducing bacteria. Indeed, incubation of siroheme with AhbA/B also re-
sulted in the complete conversion of siroheme into didecarboxysiroheme (11). The
relationship between the Nir proteins associated with heme d1 synthesis and the Ahb
proteins of heme synthesis is shown in Fig. 12. The identiﬁcation of siroheme as an
intermediate for the biosynthesis of heme d1 and the alternative heme biosynthetic
pathway made it immediately clear how the two pathways must work and explained
the commonality of the genes required for their biosynthesis.
For heme d1 synthesis, siroheme is produced through a combination of a SUMT
(NirE), a precorrin-2 dehydrogenase, and a sirohydrochlorin ferrochelatase (183). In P.
denitrificans, this ferrochelation is mediated by a CbiX-like protein (12), which is a
member of the type II chelatase family (184) and displays signiﬁcant structural similarity
to the cobaltochelatases (185, 186). Chromosomal inactivation of this cbiX gene in P.
denitrificans prevents respiration on nitrate, thereby conﬁrming the role of siroheme in
heme d1 synthesis (12). Siroheme is next converted into 12,18-didecarboxysiroheme by
a siroheme decarboxylase that is formed from NirDL, NirG, and NirH. NirDL also appears
to perform decarboxylation by itself but is more efﬁcient in the presence of NirG and
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NirH (11). The reaction is both oxygen and cofactor independent and is analogous to
the decarboxylation reactions mediated by the uroporphyrinogen III decarboxylase
UroD. Following the decarboxylation reaction, didecarboxysiroheme undergoes a loss
of the propionate acid side chains in a reaction catalyzed by NirJ (11), which is a
member of the radical SAM family (187). Such a reaction would generate a dihydro-
heme d1 molecule, which then has to undergo dehydrogenation of the propionate acid
side chain attached to C-17 to give the acrylate functionality and generate heme d1. In
fact, although the NirJ reaction has not yet been demonstrated, the formation of the
double bond on the C-17 propionate has been shown to be mediated by NirN within
the periplasm (188, 189). This was demonstrated when a NirN knockout gave rise to a
NirS enzyme containing dihydro-heme d1. Moreover, NirN was then shown to convert
dihydro-heme d1 into heme d1, most likely by employing an electron bifurcation
mechanism for this 2-electron oxidation, utilizing both the cytochrome c prosthetic
group and the heme d1 product (188). The role of NirF in this biosynthetic process is still
to be elucidated, but interestingly, it too is located within the periplasm (189, 190). How
dihydro-heme d1 gets across the membrane is unknown.
The Siroheme Branch to Protoheme
The alternative heme biosynthesis pathway can also be explained in relatively
simple terms with the knowledge that siroheme is a key primogenitor (Fig. 12).
Archaeal genome data mining revealed that organisms that require heme also have the
genes that encode the enzymes for siroheme synthesis. After siroheme is made, it is
converted to 12,18-didecarboxysiroheme through the action of AhbA and AhbB, in a
reaction identical to that mediated by NirDL, NirG, and NirH (11). The elimination of the
two acetic acid residues attached to C-2 and C-7 of didecarboxysiroheme generates
Fe-coproporphyrin (coproheme). The oxidative decarboxylation of the two propionates
on C-3 and C-8 then yields heme. This series of reactions was proven to be correct when
FIG 12 The alternative heme biosynthetic pathway via siroheme as an intermediate. Precorrin-2 is converted into siroheme via
sirohydrochlorin by utilizing the siroheme biosynthetic enzyme system. Siroheme then undergoes decarboxylation of the acetic acid
side chains attached to C-12 and C-18 to generate didecarboxysiroheme. The loss of the acetic acid side chains attached to C-2
and C-7 is mediated by a radical SAM enzyme, AhbC, to give Fe-coproporphyrin (coproheme). The ﬁnal step in biosynthesis is
mediated by another radical SAM enzyme, AhbD, which promotes the loss of the carboxylic acid groups on the propionate side chains
attached to C-3 and C-8 to generate heme.
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it was demonstrated that incubation of 12,18-didecarboxysiroheme with AhbC, a
radical SAM enzyme, together with SAM was enough to transform the substrate into
Fe-coproporphyrin III (11). Finally, AhbD, another radical SAM enzyme, was able to
mediate the transformation of Fe-coproporphyrin III into heme in the presence of SAM
by promoting the decarboxylation of the two propionate side chains to give vinyl
groups (11). This ﬁnal step is analogous to the reaction on the classic pathway catalyzed
by CgdH, which is also a radical SAM enzyme.
The alternative heme biosynthesis pathway also explains the observations made by
Ishida and colleagues when they tried to dissect the pathway (46). In essence, when
they isolated intermediates from either whole cells or cell extracts, they then esteriﬁed
the intermediates with methanol and sulfuric acid to generate the more solvent-soluble
methyl ester derivatives. However, this process also removed the iron from the tet-
rapyrrole, and hence, when those researchers isolated the extracted compounds by
chromatography and mass spectrometry, they observed only sirohydrochlorin, 12,18-
didecarboxysirohydrochlorin, coproporphyrin III, and protoporphyrin IX rather than the
Fe-containing intermediates.
The role of siroheme in the alternative heme pathway was key to its elucidation.
Siroheme was not expected to act as an intermediate, as it was assumed, wrongly, that
iron chelation would be the ﬁnal step as it is in the classic pathway. The role of
siroheme also explains why Ishida and colleagues were unsuccessful in the accurate
description of the pathway. From this research, it was concluded that the alternative
heme biosynthesis pathway progresses by using siroheme as a key biosynthetic
intermediate, as is outlined in Fig. 12. There are many unanswered questions concern-
ing the individual enzymes in the biosynthesis of both heme and heme d1. However,
some insights into the decarboxylation of siroheme have been deduced from the
structure determinations of AhbA/B of D. desulfuricans and Hydrogenobacter thermo-
philus NirDL (191, 192). In the latter case, unlike most other heme d1 synthesis systems,
NirD/L works in the absence of a NirG or NirH. The structures of both enzymes reveal,
as expected, similarity to the Lrp/AsnC family of transcription factors (191, 192). A large
active site is formed between the two subunits, and crystallization with either a
substrate analog (Fe-uroporphyrin III) (191) or product (12,18-didecarboxysiroheme)
(192) has allowed models for the decarboxylation of the kinetically stable carboxyl
groups on the substrate to be proposed. These mechanisms involve a number a
conserved residues involving histidine, tyrosine, and arginine residues.
TWO BRANCHES TO SYNTHESIZE PROTOHEME
Uroporphyrinogen Decarboxylase
Protoheme is synthesized by archaea and denitrifying and sulfate-reducing bacteria
via the siroheme-dependent pathway detailed above. For all other bacteria, a distinct
protoheme synthesis branch exists. In all of these organisms, the ﬁrst step of the
pathway toward protoheme is the conversion of uroporphyrinogen III into copropor-
phyrinogen III. The enzyme responsible for this is named uroporphyrinogen III decar-
boxylase (UroD) (EC 4.1.1.37) (14, 193).
UroD catalyzes the stepwise decarboxylation of each of the four pyrrole ring acetic
acid side chains, yielding four methyl groups at the C-2, C-7, C-12, and C-18 positions
(also numbered ring side chains 1, 3, 5, and 8, respectively) (Fig. 13A). Early studies on
the uroporphyrinogen decarboxylase enzyme mechanism focused on the order of
decarboxylation and were conducted largely on the metazoan form of the enzyme. The
rationale for this choice was the known linkage between the disease porphyria cutanea
tarda (PCT) and diminished UROD activity levels (194). An excellent review of early
chemically based studies by Jackson’s group (195) is available, which outlines the
experiments that helped to determine the stepwise decarboxylations that start with the
D ring and proceed clockwise to the A, B, and, ﬁnally, C rings (196). UROD utilizes both
the I and III isomers of uroporphyrinogen as well as all 14 possible intermediates
between uroporphyrinogen and coproporphyrinogen. Interestingly, the enzyme cata-
lyzes this reaction without any associated cofactor.
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To date, all major studies on the enzyme’s mechanism have been carried out with
the human enzyme. The enzyme from R. capsulatus was identiﬁed in 1995, but no
biochemical studies have been reported (197). An X-ray crystallographic structure at 2.3
Å of B. subtilis UroD was reported in 2007 (198), but there have been no follow-up
studies. The Protein Data Bank (PDB) contains a 1.95-Å structure (accession number
4WSH) of a “probable” UroD enzyme from P. aeruginosa as well as a 1.9-Å structure (PDB
accession number 2EJA) from Aquifex aeolicus, a 2.8-Å structure (accession number
3CYV) from Shigella flexneri, and a 1.6-Å structure (accession number 4EXQ) from
Burkholderia thailandensis. Of these structures deposited in the PDB, only the one
reported under PDB accession number 4EXQ has an associated publication, which is the
report of a structural genomic study of 406 putative essential genes of B. thailandensis
(199). No biochemical studies were carried out on any of these UroD proteins.
The X-ray crystal structures reveal that UROD from human (200, 201) and Nicotiana
tabacum (202) and the listed structures for bacterial UroDs are homodimers of 40 kDa
per subunit, with the two active-site clefts being adjacent to the dimer interface and
with no associated cofactor or prosthetic group. The latter observation validated the
proposal that the enzyme is unique in that it catalyzes decarboxylations without any
cofactor. Nevertheless, the bacterial UroD enzymes are structurally highly similar to the
human and tobacco enzymes, even though there is only about 37% amino acid
sequence identity. The main difference between the structures of the human and B.
subtilis enzymes is a subtle movement of two small surface loops (L1 and L2). The
spatial orientation of conserved active-site residues of the UroD enzymes is highly
similar to that of the human structure, suggesting that the catalytic mechanisms of
these proteins are identical.
FIG 13 Uroporphyrinogen decarboxylase (UroD). (A) Overall reaction of four sequential decarboxylations.
The acetic acid side chains that are removed are highlighted in red circles. Details of the reaction are
outlined in the text. (B) Active site of human UROD with a bound product (coproporphyrinogen III). While
structures of bacterial UroDs are available, there are none with a bound substrate or product. However,
given the homology between the bacterial and human enzymes, one would assume that the reaction
mechanism is the same. The positions of the essential Asp residue and four Arg residues are shown.
Numbering is according to that of the human enzyme.
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A structure of human UROD with the product coproporphyrinogen III bound
revealed that the substrate/product binds as a dome-shaped molecule with the four
pyrrole NH groups facing inward within hydrogen-bonding distance of a conserved Asp
residue (Fig. 13B). The tilt of the four pyrrole rings relative to the plane that passes
through the four N atoms ranges from 12° for the C ring to 35°, 45°, and 58° for the
B, D, and A rings, respectively. The active-site pocket is relatively hydrophobic but is
ringed with charged residues that include the three conserved Arg residues, one
conserved His residue, and one conserved Tyr residue (203). These polar residues have
been suggested to interact with the propionate side chains of the tetrapyrrole to
spatially orient the substrate, although it has been strongly suggested that one of the
Arg residues participates in the catalytic cycle. One model proposes that the conserved
Asp residue donates a proton to the substrate pyrrole ring adjacent to the acetate side
chain (204). This results in decarboxylation, creating an intermediate and requiring that
the conserved Arg residue contribute a proton to the methylene group as the ring is
deprotonated by the Asp side chain. Regardless of the exact mechanism, it has been
suggested that UROD is a “benchmark” for catalytic proﬁciency among enzymes
without cofactors, with an estimated value for enzyme enhancement of the decarbox-
ylation reactions of 1017 (204).
As mentioned above, UROD is a homodimer with juxtaposed and facing active sites.
Given that four decarboxylations of a single uroporphyrinogen molecule are required
for the production of coproporphyrinogen, there are at least three distinct models that
may be considered. In one model, the homodimer shuttles, or channels, a single
porphyrinogen back and forth between active sites without equilibration with a bulk
solvent. The second model is a variation of the ﬁrst model where transfer between
active sites could occur, but there is not obligatory channeling and equilibration with
bulk medium. In the third model, the substrate remains in a single active site and would
rotate 90° following each decarboxylation until all four acetyl side chains are converted
to methyl groups. To address this question, experiments in which the two subunits of
the homodimeric UROD were tethered together were conducted (205). In this con-
struct, one monomer’s active site was left unaltered, and the second monomer’s active
site was mutated to result in a catalytically impaired monomer. This engineered enzyme
was active, yielding the expected four decarboxylated products, demonstrating that
shuttling between subunits is not necessary for activity. Taking advantage of the fact
that UROD utilizes both the I and III isomers of uroporphyrinogen and that the I and III
isomers and resulting decarboxylation products can be independently identiﬁed via
HPLC, a series of experiments demonstrated that porphyrinogen release and equilibra-
tion with bulk medium occurred following each decarboxylation in the in vitro assay
system. Thus, the experimental data are inconsistent with obligatory channeling and/or
substrate rotation without intermediate release. However, given the reactive nature of
the porphyrinogen substrates, one may anticipate that generalized release to and
equilibration with bulk medium would be inefﬁcient in vivo.
The Coproporphyrin-Dependent Branch
Among bacteria, with the exception of sulfate-reducing and denitrifying bacteria
(11), protoheme synthesis necessarily involves the intermediate coproporphyrinogen III.
This is true for all eukaryotes as well. It has long been known that in eukaryotes, the
pathway from uroporphyrinogen III involves the decarboxylation of uroporphyrinogen
III to coproporphyrinogen III, followed by the oxidative decarboxylation of copropor-
phyrinogen III to protoporphyrinogen IX, the oxidation of this to protoporphyrin IX,
and, ﬁnally, the insertion of iron to create protoheme (32). This has frequently been
referred to as the classic pathway, and until recently, it was believed to be universal in
protoheme-synthesizing bacteria. This generic model was demonstrated to be incorrect
with the discovery that Gram-positive bacteria utilize an alternate route, which can be
viewed as an evolutionary transition between the siroheme-dependent pathway found
ﬁrst in archaea and described above and the classical pathway found in Gram-negative
bacteria and eukaryotes (35, 43, 44). We refer to this pathway as the coproporphyrin-
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dependent (CPD) branch since it uniquely contains coproporphyrin III as an interme-
diate (Fig. 14). The coproporphyrin-dependent pathway is found in Gram-positive
bacteria and a few bacteria that are transitional between Gram-positive and Gram-
negative bacteria, such as Deinococcus (35, 44), but has not been found in archaea,
eukaryotes, or Gram-negative bacteria. In the CPD pathway, coproporphyrinogen III is
ﬁrst oxidized to coproporphyrin III by coproporphyrinogen oxidase (CgoX), iron is
inserted to make coproheme III by coproporphyrin ferrochelatase (CpfC), and, ﬁnally,
coproheme is decarboxylated to protoheme by coproheme decarboxylase (ChdC). It is
of note that neither the coproporphyrin-dependent nor the siroheme-dependent
pathways have protoporphyrinogen or protoporphyrin as intermediates. The evolu-
tionary signiﬁcance of this is not immediately apparent, but since chlorophyll synthesis
requires protoporphyrin, the advent of chlorophyll-based photosynthesis could not
have occurred prior to the evolution of the protoporphyrin-dependent (PPD) pathway
discussed later in this review.
Porphyrin oxidation by coproporphyrinogen oxidase (CgoX). The ﬁrst committed
step in the CPD pathway is the oxidation of coproporphyrinogen III to coproporphyrin
III. The enzyme responsible for this reaction was named HemY when it was ﬁrst cloned,
expressed, and characterized in B. subtilis and was believed to be a protoporphyrinogen
oxidase (206–208). Interestingly, those groups reported that B. subtilis HemY catalyzed
the oxidation of coproporphyrinogen to coproporphyrin at a rate higher than that at
which it oxidized protoporphyrinogen to protoporphyrin. With the recent elucidation
of the CPD pathway and to prevent confusion with protoporphyrinogen oxidase (also
previously named HemY), we now name this enzyme coproporphyrinogen oxidase
(CgoX).
Most of what we currently know about this enzyme comes from studies on the B.
subtilis and Staphylococcus aureus enzymes (43, 206–208). The reaction catalyzed is the
six-electron oxidation of coproporphyrinogen III to coproporphyrin III. In the in vitro
reaction, three molecules of molecular oxygen accept the six protons from the por-
phyrinogen, forming three molecules of H2O2 and the oxidized porphyrin (Fig. 15). This
reaction converts the ﬂexible, cyclic tetrapyrrole porphyrinogen into the fully conju-
gated, planar macrocyclic porphyrin. CgoX is a ﬂavin adenine dinucleotide (FAD)-
containing, soluble, monomeric protein with a molecular mass of 50 kDa. Since there
is only a single FAD, it is clear that the full six-electron reaction must proceed via three
two-electron steps, yielding the tetrahydro and dihydro intermediates, although this
has yet to be demonstrated experimentally. S. aureus CgoX has been reported to utilize
coproporphyrinogen III, but not protoporphyrinogen IX, as a substrate, with a Km of 0.3
M and a kcat of 1.3 min1 (43). CgoX of B. subtilis can oxidize both coproporphyrino-
gen III and protoporphyrinogen IX but at signiﬁcantly different rates (206–208). This
CgoX enzyme is reported to have a Km of 0.6 M and a Vmax of 7.0 min1 with
coproporphyrinogen III, compared with a Km of 1.3 M and a Vmax of 0.8 min1 with
protoporphyrinogen IX. As discussed below, the diphenyl ether herbicide aciﬂuorfen,
FIG 14 The coproporphyrin-dependent pathway to protoheme. The pathway from coproporphyrinogen III to protoheme is shown along
with the structures of the intermediates and enzymes responsible for each reaction. Details for each individual step are outlined in the
text and in ﬁgures below.
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FIG 15 (A) Conversion of porphyrinogen to porphyrin. The conversion of coproporphyrinogen to
coproporphyrin is catalyzed by CgoX, while the conversion of protoporphyrinogen to protoporphyrin is
catalyzed by the homologous protein PgoX. The only difference between the two reactions is that CgoX
acts upon coproporphyrinogen, while PgoX acts upon protoporphyrinogen. For coproporphyrinogen, “R”
groups on the diagram are propionates, while for protoporphyrinogen, R groups are vinyls. The reaction
in vitro utilizes three molecules of molecular oxygen and produces three molecules of hydrogen
peroxide. Below the structure drawings are three-dimensional representations of coproporphyrino-
gen and coproporphyrin. The A- and B-ring propionates of coproporphyrinogen III, which are vinyl
groups in protoporphyrinogen IX, are outlined in red. The diagram illustrates the ﬂexibility of the
porphyrinogen allowed by the presence of the four saturated methyl mesobridges in the tetrapyr-
role compared to the planarity of the aromatic porphyrin macrocycle. (B) Cartoon structure of the
active site of B. subtilis CgoX (blue) on M. xanthus PgoX (yellow) (PDB accession numbers 3I6D and
2IVD, respectively) showing the close similarity of the structures of the two proteins. The overlaid
FAD molecules are shown in a black stick representation, and the positions of the two inhibitor
aciﬂuorfen molecules are shown in turquoise. Previously, others presented the B. subtilis CgoX
structure with a molecule of protoporphyrinogen modeled into the active site based upon the
positions of the aciﬂuorfen molecules (211). However, in the absence of clearly identiﬁed catalytic
residues along with a lack of knowledge about potential molecular rearrangements that may occur
upon substrate binding, we did not reproduce that model. (C) Cutaway view through the active site
of B. subtilis CgoX. The position of the aciﬂuorfen is shown as black sticks, and FAD is in yellow. This
view illustrates the spacious active-site pocket that can easily accommodate the tetrapyrrole
molecule. Both panels B and C show the close proximity of the ﬂavin and inhibitor ring structures.
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which effectively inhibits eukaryotic and Gram-negative protoporphyrinogen oxidases,
is a poor inhibitor of CgoX, although other compounds in this class, such as oxyﬂuorfen,
inhibit the enzyme at low-micromolar concentrations.
Two X-ray crystallographic structures for CgoX enzymes of Gram-positive bacteria
have been deposited in the PDB. One of these, at 2.06 Å, for the Exiguobacterium sp.
strain SP255-15 enzyme (PDB accession number 3LOV), was determined by the Joint
Center for Structural Genomics effort and has no associated publication. The second
structure, at 2.9 Å, is for the B. subtilis protein (PDB accession number 3I6D) (Fig. 15) and
is associated with a previous report by Qin et al. (209) that contains discussion about
the structure as well as some enzyme kinetics of the wild type and several variants.
These two structures are highly similar to the reported structures of protoporphyrino-
gen oxidase of the Gram-negative bacterium Myxococcus xanthus (210) and the human
(211) and tobacco (212) proteins. The root mean square deviation (RMSD) between C-
atoms of B. subtilis CgoX and the eukaryotic enzymes is 1.5 to 1.8 Å, which compares
favorably with the RMSD between the two Gram-positive CgoX structures (1.7 Å).
There are two distinctions between the Gram-positive CgoXs and the protoporphy-
rinogen oxidases described below. The ﬁrst of these distinctions is the size of the
putative active-site pocket. In the CgoXs, this region is signiﬁcantly larger than that
found in protoporphyrinogen oxidase. B. subtilis CgoX has a pocket calculated to be
1,173 Å3, compared with 627 Å3 and 440 Å3 for the M. xanthus and human enzymes
(209), respectively. The second difference is that the CgoX active-site pocket has more
positively charged surface areas than those found in the protoporphyrinogen oxidase
structures. Both of these observations are consistent with the binding by CgoX of
coproporphyrinogen III as the substrate, which has larger and negatively charged
propionates at the 3 and 8 positions on the A and B pyrrole rings compared with the
smaller, uncharged vinyl groups present at these two positions in protoporphyrinogen.
Porphyrin metalation by coproporphyrin ferrochelatase (CpfC). Following the
oxidation of coproporphyrinogen to coproporphyrin, a metal chelatase, coproporphy-
rin ferrochelatase (CpfC), catalyzes the insertion of ferrous iron to form coproheme III.
Metal chelatases identiﬁed to date fall mainly into two broad classes (213). One group,
class I, is composed of ATP-dependent heteromeric complexes, and the second group,
class II, is composed of ATP-independent monomeric or homodimeric proteins. En-
zymes of class I include Mg chelatases for both chlorophyll and bacteriochlorophyll
(BchD, BchH, and BchI), aerobic cobalamin biosynthetic cobalt chelatases (CobN), and
probably an uncharacterized Ni chelatase for the synthesis of coenzyme F430. Members
of class II are the sirohydrochlorin ferrochelatase (SirB), the anaerobic cobalamin
biosynthetic cobalt chelatases (CbiK and CbiX), coproporphyrin III ferrochelatase (CpfC),
and protoporphyrin IX ferrochelatase (PpfC). A third smaller class of chelatases, class III,
is a group of enzymes possessing both dehydrogenase and iron chelation abilities. To
date, class III chelatases are known only for siroheme biosynthesis (CysG and Met8p)
(169). The class II chelatases, of which coproporphyrin and protoporphyrin ferrochela-
tases are members (Fig. 16), are generally deemed as being more simple enzymes given
their size and lack of heteromeric tertiary structure (184, 214–217). However, even these
simple proteins appear to utilize relatively complex methods to achieve their goal
(217–221). From an evolutionary and gene size viewpoint, the most simple of the class
II chelatases is CbiXs of Archaeoglobus fulgidus and other archaea (185). There is minimal
amino acid sequence identity among all ferrochelatases, but there is clear structural
homology among members of this group, and the few conserved residues are generally
found in the active-site pocket.
Coproporphyrin ferrochelatase is found only in bacteria that possess the CPD
pathway (35). Archaea do not have either coproporphyrin or protoporphyrin ferroche-
latases and form protoheme via a coproheme intermediate that is derived from the
already metallated siroheme and not coproporphyrin (11, 42). Eukaryotes and Gram-
negative bacteria all possess a protoporphyrin-speciﬁc ferrochelatase. The true identity
of CpfC as a chelatase with speciﬁcity for coproporphyrin, rather than protoporphyrin,
as is found for PpfC, was revealed with the discovery of the CPD pathway (35, 43). Both
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coproporphyrin and protoporphyrin ferrochelatases catalyze the insertion of divalent
iron, cobalt, nickel, or zinc into coproporphyrin (43, 215).
The best-characterized CpfC enzyme is that from B. subtilis (222–227). In this
organism, as with all ﬁrmicutes, the enzyme is a water-soluble, monomeric protein with
FIG 16 Iron insertion by ferrochelatase. Two ferrochelatases are described in the text. One, CpfC, catalyzes the insertion of ferrous iron
into coproporphyrin III, and the other, PpfC, inserts iron into protoporphyrin IX. Both ferrochelatases are structurally homologous and
probably possess the same catalytic features. (A) The PpfC reaction. This reaction differs from the CpfC reaction in the presence of the
vinyl groups on the A and B rings of protoporphyrin, which are propionates for coproporphyrin for the CpfC reaction. (B) Cartoon
structures of B. subtilis CpfC, in wheat color on the left (PDB accession number 1C1H), and human ferrochelatase (the best-
characterized PpfC enzyme), in yellow on the right (PDB accession number 2QD1). The red arrows point to the position of the bound
porphyrin in the active sites. It should be noted that no structures of a CpfC enzyme with the bound substrate porphyrin or a product
are available in the PDB, so the structure with the tight-binding, competitive inhibitor N-methylmesoporphyrin is shown. PpfC
enzymes possess a larger lip on the active site that closes over the “mouth” when porphyrin is bound. This enclosure of the active
site precludes the binding of coproporphyrin with its propionate groups on the A and B rings. (C) Cartoon representation of the active
site of human ferrochelatase illustrating the positions of conserved active-site residues in relation to the bound porphyrin substrate.
Current models for enzyme function propose that the essential His residue is the acceptor for the two pyrrole nitrogen protons, Lys
and Tyr help align the porphyrin macrocycle in the active site, and Met (Tyr in some CpfC enzymes) is the site of iron donation. Details
and alternative models are presented in the text. (D) Ribbon cartoon representation demonstrating the three structural conformations
of human ferrochelatase. The substrate-free resting state is wheat colored. Upon binding of the porphyrin substrate, the upper lip
(shown in green) closes the active-site pocket. (E) Following metalation, the lower lip/-helix extends (shown in red) to facilitate
product release. Upon metalation, the 14-propionate (C ring) of heme ﬂips conformation. This is accompanied by a reorientation of
the essential His residue, and this movement is proposed to cause pocket opening and -helix extension.
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a molecular mass of about 35 kDa and no bound cofactors or metals. CpfCs from
actinobacteria have also been shown to preferentially utilize coproporphyrin II as the
substrate (35). These enzymes are water soluble, monomeric proteins with molecular
masses of 41 kDa and possess a [2Fe-2S] cluster (228). As with the well-characterized
human ferrochelatase that has a [2Fe-2S] cluster, the clusters of the actinobacterial
CpfCs coordinate the irons of the [2Fe-2S] cluster via one internal and three carboxyl-
terminal cysteine residues (215, 228). At present, the role played by the [2Fe-2S] cluster
has not been identiﬁed.
A number of X-ray crystallographic structures at about a 2-Å resolution have been
determined for wild-type and variant forms of B. subtilis CpfC (222–227). Additionally,
structures with the inhibitor N-methylmesoporphyrin (NMMP) and 2,4-disulfonic acid
deuteroporphyrin IX (dSDP) (similar to coproporphyrin III but with sulfonate groups
replacing the propionate groups of the A and B rings) have been determined. In neither
of these structures is the porphyrin macrocycle in the same spatial position and
orientation within the active-site pocket as those found with the substrate- and/or
product-bound human ferrochelatase. Additionally, NMMP and dSDP do not bind in the
same position or orientation (relative to each other) within the CpfC active site.
Unfortunately, no structures of any bacterial CpfC enzyme with the substrate or product
bound have been reported. Thus, at present, it is not possible to unequivocally
determine a catalytically relevant binding orientation for coproporphyrin III within the
CpfC active-site pocket or assign roles served by speciﬁc residue side chains.
The structures that are available reveal an active-site pocket of a sufﬁcient size to
engulf the four pyrrole rings of the porphyrin macrocycle (Fig. 16B). Within the pocket
is an invariant and essential histidine residue found in all ferrochelatases that has been
proposed to be involved in binding the substrate iron and/or serving as an acceptor for
the pyrrole nitrogen protons that are removed to allow metal insertion (215, 218, 229).
There is also a highly conserved -helix with a patch of conserved acidic residues that
has been shown for human ferrochelatase to be mobile and essential for the catalytic cycle
(217, 220). Although the primary sequences of the human and B. subtilis enzymes are 15%
identical, their structures are highly similar, with an RMSD of 2.4 Å for C- atoms, and the
active-site pockets contain most of the conserved residues. Given the structural and
enzymological similarities, it is quite likely that both enzymes utilize the same catalytic
mechanism. Why it is that the Gram-positive CpfCs utilize coproporphyrin as the substrate
while protoporphyrin ferrochelatases do not is most likely attributable to the absence of a
dozen residues in CpfCs that form a “lip” on one side of the active site on protoporphyrin
ferrochelatases (35, 224). In the ferrochelatases that possess this lip, the lip closes down over
the active-site pocket during the catalytic cycle (219, 220). In this closed position, there is
insufﬁcient space within the pocket for the 3,8-propionate side chains of the A and B rings
of coproporphyrin (35). The coproporphyrin ferrochelatases lack this lip, so even with the
expectedmolecular movement during catalysis, the pocket would remain open on one side
to allow for the two propionate side chains of the A and B rings to project into the
surrounding milieu (Fig. 16B).
Decarboxylation of coproheme III to protoheme. The last step in the coproporphyrin-
dependent pathway is the decarboxylation of coproheme III to protoheme. In the
siroheme-dependent branch discussed above, the conversion of coproheme to proto-
heme was shown to be catalyzed anaerobically by the enzyme named AhbD (11). AhbD
is a putative radical SAM enzyme that was initially reported to be found only in
denitrifying and sulfate-reducing bacteria and in protoheme-synthesizing archaea (11,
42) but has recently been identiﬁed in Gram-positive bacteria that possess the CPD
pathway. In CDP pathway-using organisms, coproheme is an intermediate product
synthesized by CgoX/CpfC and used as a substrate by the enzyme coproheme decar-
boxylase (ChdC), which catalyzes the oxidative decarboxylation of the A- and B-ring
propionates into vinyl groups to form protoheme (Fig. 17) (206–208). Thus, the com-
plete coproporphyrin-dependent pathway in Gram-positive bacteria requires the action
of CgoX plus CpfC plus ChdC. Protoporphyrin is not an intermediate as is found for
heme-synthesizing Gram-negative bacteria and eukaryotes. This explains why the
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complementation of E. coli lacking either protoporphyrinogen oxidase or protoporphy-
rin ferrochelatase requires the presence of CgoX, CpfC, and ChdC acting in unison (35).
Interestingly, the lack of protoporphyrin in all examined Gram-positive bacteria and the
early observation that cell extracts of the Gram-positive bacterium Micrococcus lyso-
deikticus (31) could produce coproheme hinted long ago at what was recently dem-
onstrated (35, 43, 44).
While they share the same substrate and product, ChdC has no similarity to AhbD.
In fact, ChdC is a member of the chlorite dismutase family (Clds) and was originally
annotated as a possible chlorite dismutase, even though most organisms possessing
this gene lacked the ability to metabolize chlorite (19, 35, 44). Crystal structures are
available for a number of chlorite dismutases and several ChdCs (PDB accession
numbers 1T0T, 3DZT, 1VDH, 4WWS, and 5LOQ). Both enzymes are soluble homopen-
tamers with subunit molecular masses of 30,000 Da, and both enzymes assemble into
a structure that resembles a tall donut with heme-binding pockets located on the
outside rim at one end (Fig. 17B). The crystal structures for all chlorite dismutases have
bound protoheme, but only ChdC of Listeria monocytogenes has a bound heme, and
this is the substrate coproheme (230) (Fig. 17C). ChdC is found in both heme-
synthesizing ﬁrmicutes and actinobacteria. While the proteins are clearly similar and
share conserved active-site residues, ﬁrmicute ChdC differs from actinobacterial ChdC
in that it possesses an additional 8 to 12 residues that form a lip adjacent to the
putative active site (35, 44). This feature, which has been suggested to be ﬂexible and
to possibly serve a gatekeeper function for the active site (231), is visible in only two
subunits (subunits A and D) of the crystal structure of coproheme-bound L. monocy-
FIG 17 Decarboxylation of coproheme III to form protoheme IX. (A) Reaction catalyzed by the terminal enzyme in the CPD
pathway, ChdC. The two propionates that are converted to vinyl groups are circled in red. The reaction goes through a
monovinyl monopropionate deuteroheme intermediate. (B) Structure of ChdC from Geobacillus stearothermophilus (PDB
accession number 1T0T) with the putative active-site pocket shown in red. On the left is a space-ﬁlling model, and on the right
is the same protein rotated 90° and shown in a ribbon format to illustrate the hole through the middle of the pentamer
doughnut. (C) Structure of L. monocytogenes CpdC with bound coproheme (PDB accession number 5LOQ). The residues shown
are the conserved His174 residue (which is ligated to the iron of the coproheme) as well as Arg133 and Lys151. The latter two
residues are hydrogen bonded to the propionates of rings C and D (230). This pocket tightly binds heme, so there must be
some structural difference for ChdC to allow the substrate to bind and the product to be released.
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togenes ChdC. The fact that actinobacterial ChdCs do not possess this loop feature
suggests that if it serves a function, it is not essential for enzyme activity. Interestingly,
the active-site residues are relatively conserved between chlorite dismutase and ChdC,
which has allowed models of heme binding within the ChdC active site to be proposed
(231). The L. monocytogenes crystal structure clearly demonstrates the orientation of
coproheme within the active site and reveals that coproheme is anchored by a
conserved proximal histidine residue (230). Unfortunately, the heterogeneity in the
orientations of the proposed essential side chains as well as the fact that few active-site
residues are conserved between ﬁrmicute and actinobacterial ChdC enzymes leave a
number of questions about catalysis unresolved.
The reaction occurs in a stepwise fashion, much like what is seen with UroD. The
A-ring propionate is ﬁrst decarboxylated, yielding the intermediate monovinyl mono-
propionate deuteroheme IX (231) (Fig. 17A). This is then decarboxylated in a reaction
that is signiﬁcantly slower than the ﬁrst reaction to yield the ﬁnal product protoheme.
It has been shown that both the III and IV isomers of the monovinyl monopropionate
deuteroheme can be decarboxylated, although the IV isomer (propionate on the A ring)
reacts more rapidly, but even the “fast” reaction is relatively slow, with a half-life (t1/2)
of 1 to 2 s. Lacking structural data for the monovinyl monopropionate intermediate-
bound ChdC enzyme, it is not possible to say if the macrocycle rotates to move the B
ring into the previous A-ring site, thus replacing the B ring with the C ring as it goes
from the decarboxylation of the A ring to the B ring, or if the macrocycle is ﬂipped,
essentially replacing the A ring with the B ring and vice versa. The second model would
be favored if the alignment of the substrate heme within the active site involves the
propionates of the C and D rings, since inversion of the macrocycle of the coproheme
III/protoheme IX isomers would leave the 13,17-position propionates of the C and D
rings unaltered. If, however, the absolute position of the propionate being decarboxy-
lated with respect to the overall macrocycle in the active site is the essential feature,
then the rotation model would be favored. Also, the fate of the released carboxylate is
yet to be demonstrated. As is the case with the CgdC reaction, the expectation is that
this is released as CO2, but data conclusively showing this have yet to be presented.
Possible reaction pathways have been proposed, and they all involve the participation
of the heme iron (19, 43, 231). This is consistent with the observation that cobalt-
coproporphyrin III is not decarboxylated (35, 44).
ChdC decarboxylation reactions require the presence of a proton acceptor. When a
variety of possible common acceptors (e.g., NADP, NAD, FAD, and ﬂavin mononucle-
otide [FMN]) were tried in in vitro assays, only FMN supported turnover and product
formation (35, 44). Since the previous reaction of CgoX results in the in vitro production
of three molecules of H2O2 for each coproporphyrinogen molecule oxidized, there is a
possibility that these peroxides could serve as acceptors for the ChdC reaction. This
proposition was additionally supported by the observation that in the presence of
puriﬁed recombinant CgoX plus CpfC plus ChdC, coproporphyrinogen III plus ferrous
iron are stoichiometrically converted into protoheme IX (35, 43). However, incubation
of CpfC plus ChdC (no CgoX) with coproporphyrin III plus ferrous iron yielded only
coproheme and not protoheme. Finally, it was shown that in the presence of H2O2,
ChdC alone catalyzes the conversion of coproheme to protoheme. Interestingly the ﬁrst
decarboxylation occurs in the presence of one equivalent of H2O2, as anticipated, but
the second decarboxylation is reported to require 5 to 10 equivalents of H2O2 in ChdC
of S. aureus (43, 231) but only 1 equivalent for ChdC of L. monocytogenes (230).
Bioinformatic analysis revealed that some Gram-positive bacteria possess both chdC
and ahbD (35). In fact, in Gram-positive bacteria, ahbD is found more frequently with
chdC and cpfC than it is found with ahbABC, and some chdC- and cpfC-containing
Gram-positive organisms possess only ahbD and not chdC.
The Protoporphyrin-Dependent Branch
The protoporphyrin-dependent branch is commonly called the classic pathway,
since it was the ﬁrst one to be discovered and was long believed to be the sole
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biosynthetic route to protoheme (Fig. 18). It is now recognized that while this is the
single pathway utilized in eukaryotes, among prokaryotes, it is found only within
Gram-negative bacteria. The ﬁrst committed step, the conversion of coproporphyrino-
gen III into protoporphyrinogen IX, requires the oxidative decarboxylation of the
propionate side chains on rings A and B of the substrate to the corresponding vinyl
groups (232–234) (Fig. 19). Currently, two different, structurally and mechanistically
unrelated enzymes are known to catalyze this reaction (234, 235). Coproporphyrinogen
decarboxylase (CgdC) requires molecular oxygen for this reaction. Most eukaryotes and
a small group of Gram-negative bacteria utilize this enzyme for aerobic heme and
chlorophyll biosynthesis (236). The second enzyme, coproporphyrinogen dehydroge-
nase (CgdH), is oxygen independent and utilizes a radical SAM mechanism (14, 33).
Both enzymes catalyze the decarboxylation of ring A prior to that of ring B with the
formation of a monovinyl monopropionate deuteroporphyrin intermediate (237–239).
Conversion of coproporphyrinogen III into protoporphyrinogen IX. (i) Oxygen-
dependent coproporphyrinogen III oxidase (CgdC). In 1961, Sano and Granick re-
ported the ﬁrst partial puriﬁcation and initial characterization of coproporphyrinogen
decarboxylase (oxidase) from bovine liver (234). Characterizations of the enzymes from
rat liver, yeast, and, later, various recombinant sources followed (232–234, 240–244).
The usually dimeric protein has been proposed to initially catalyze base-mediated
deprotonation of the pyrrole NH group, yielding an azacyclopentadienyl anion. The
reaction of this anion with molecular oxygen at the -position leads to the formation
of a pyrrole peroxide anion. The exocyclic double bond is formed by proton abstraction
at the -position of the substrate propionate side chain by peroxide and the resulting
six-membered-ring transition. The reaction concludes with the elimination of CO2 and
H2O2 followed by bond rearrangements with the formation of the product vinyl group
(160, 245–248). Currently, the structures of CgdC from yeast (PDB accession number
1TLB), human (accession number 2AEX), Leishmania major (accession number 3DWR),
Leishmania donovani (accession number 3EJO), Leishmania naiffi (accession number
3E8J), and Acinetobacter baumannii (accession number 5EO6) have been solved, with all
of them revealing an unprecedented fold for the monomer of large seven-stranded
antiparallel -sheets covered on both sides by -helices (Fig. 19). The L. major structure
was determined with the inhibitor 5-ﬂuoroindole-2-carboxylic acid bound in the active
site. A conserved aspartate residue in the active site was identiﬁed and suggested to be
the initial base for catalysis. In addition, two conserved arginine residues were pro-
posed to form hydrogen bonds with propionate side chains of the pyrrole rings so as
to properly orient the substrate in the active-site pocket (249–251).
(ii) Oxygen-independent coproporphyrinogen III dehydrogenase (CgdH). The ﬁrst
description of CgdH activity was given by Tait in 1969 and 1972 for a cell extract
prepared from R. sphaeroides (252, 253). Around 10 years later, the stereospeciﬁc loss
of the pro-S-hydrogen atom at the -carbon of the substrate propionate side chain,
identical to that shown for the CgdC reaction, was demonstrated (254). However,
FIG 18 Protoporphyrin-dependent pathway to protoheme IX synthesis. An overview of the three-step reaction and intermediates from
coproporphyrinogen to protoheme, along with the enzymes responsible for the reaction, is shown. Coproporphyrinogen III is
oxidatively decarboxylated at two propionate groups to yield protoporphyrinogen IX. This intermediate is oxidized to protoporphyrin,
which is converted into heme upon iron insertion.
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genetic approaches were necessary to identify the corresponding cgdH gene and allow
recombinant production of the E. coli enzyme, its detailed biochemical characterization,
and determination of its crystal structure (255–260) (PDB accession number 1OLT). This
enzyme is a member of the radical SAM protein family and thus contains an oxygen-
labile [4Fe-4S] cluster, ligated by 3 conserved cysteine residues of the CX3CX2C motif
and a SAM molecule. Catalysis starts by the reduction of the iron sulfur cluster by an
as-yet-unknown electron donor. Transfer of the electron from the iron sulfur cluster to
the bound SAM leads to the homolytic cleavage of SAM into methionine and the
formation of a 5=-deoxyadenosyl radical. Stereospeciﬁc abstraction of the hydrogen
atom from the substrate propionate side chain by the radical yields 5=-deoxyadenosine
and an allylic substrate radical. Transfer of the remaining electron to an unidentiﬁed
electron acceptor with the elimination of CO2 concludes the reaction (255, 257, 258).
FIG 19 Coproporphyrinogen III oxidase (CgdC). (A, left) Crystal structure of yeast CgdC (245). (Right) In the structure of human
CgdC, a citrate molecule was observed to bind, indicating the localization of the active site. (Adapted from reference 14.) (B)
Proposed reaction mechanism by which CgdC catalyzes the two oxidative decarboxylation reactions of coproporphyrinogen
III to protoporphyrinogen IX with oxygen as the terminal electron acceptor (see the text for a detailed explanation). (Adapted
from reference 246.)
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Interestingly, the crystal structure of the E. coli enzyme revealed an N-terminal domain
of a curved, 12-stranded, largely parallel -sheet decorated by -helices at its outer
surface (Fig. 20). This (/)6 repeat is structurally similar to known TIM barrel domains.
Two SAM molecules were found bound to the enzyme (256).
Oxidation of protoporphyrinogen IX. The penultimate step in the protoporphyrin-
dependent branch is the oxidation of protoporphyrinogen IX to protoporphyrin IX. This
is a six-electron oxidation, and as with the previous step, there are oxygen-dependent
and oxygen-independent enzymes. The oxygen-dependent form is found in all heme-
synthesizing eukaryotes but few Gram-negative bacteria (35, 38). The protein, named
FIG 20 Coproporphyrinogen III dehydrogenase (CgdH). (A, left) Crystal structure of E. coli CgdC. (Right) In the active site of the enzyme,
the [4Fe-4S] cluster is coordinated by the three cysteine residues of the conserved CX3CX2C sequence motif and by one of the two
bound SAM molecules. (Adapted from reference 14.) (B) Proposed reaction mechanism by which the radical SAM enzyme CgdH
catalyzes two oxidative decarboxylation reactions of the coproporphyrinogen III propionate side chains on rings A and B to the
corresponding vinyl groups of protoporphyrinogen without oxygen as the terminal electron acceptor (see the text for a detailed
explanation).
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PgoX (previously HemY) for bacteria, is a FAD-containing homodimer and utilizes
molecular oxygen as the terminal electron acceptor (261, 262). Bacterial PgoX is
homologous to the eukaryotic oxygen-dependent protoporphyrinogen oxidase en-
zymes. This enzyme is part of a FAD-containing amine oxidase superfamily (262). It is
of interest to note that there is as much sequence similarity between bacterial PgoX
and other amine oxidases, such as monoamine oxidases or phytoene desaturases, as
there is with eukaryotic protoporphyrinogen oxidase. As with AlaS and CgdH, PgoX is
an example of the evolutionary diversity of function found in some protein families.
There are structures available for protoporphyrinogen oxidases of tobacco (212) and
human (211) and PgoX of the bacterium M. xanthus (210). All of these enzymes are
membrane-associated homodimers with noncovalently bound FAD in each subunit and
a subunit molecular mass of 50 kDa. The enzyme of the hyperthermophile A. aeolicus
(263), however, has been reported to be membrane associated but monomeric. Unlike
CgoX of Gram-positive bacteria, these enzymes use protoporphyrinogen IX, but not
coproporphyrinogen III, as the substrate and are inhibited by the diphenyl ether
herbicide aciﬂuorfen at a 1 M concentration (261, 263).
The reaction mechanism of this enzyme appears identical to that of eukaryotic Ppox
and Gram-positive CgoX enzymes (Fig. 13). In vitro, the six-electron oxidation utilizes
three O2 molecules and generates three H2O2 molecules. Given that the enzyme has
only a single FAD, the reaction is assumed to proceed via three two-electron steps from
the porphyrinogen to the tetrahydro and then dihydro intermediates and ﬁnally to fully
oxidized porphyrin. The possibility that, in vivo, the enzyme may utilize an electron
acceptor other than O2 has not been examined, although it is of note that all
PgoX-possessing Gram-negative bacteria are aerobes. All mechanistic studies of this
enzyme have been done with the eukaryotic enzyme, but it is likely that the reaction
mechanism is conserved among all porphyrinogen oxidase-type enzymes. Unfortu-
nately, there are no crystal structures with a bound substrate or product that would
help to identify essential interactions between the tetrapyrrole and the enzyme.
However, there are structures with a bound inhibitor, which allowed in silico modeling
of substrate binding (210–212, 264). Based upon kinetic studies with a tritium-labeled
substrate, it was proposed that three meso-carbon hydride ions are removed from the
same surface of the tetrapyrrole in a sequential fashion with the concomitant removal
of the NH proton (265). More recently, it was suggested that all hydride abstractions
occur from the C-20 meso-carbon with total ring hydrogen rearrangements via
enamine-imine tautomerizations (212). Whether the tetrapyrrole remains bound
throughout the process or is released and rebound has not been determined. However,
if all hydride abstractions occur from the single C-20meso-carbon, it may be anticipated
that there is not intermediate release and rebinding. Overall, the reaction is relatively
slow, with a kcat of 10 s1, although selected mutations to active-site residues of
tobacco Ppox resulted in a 100-fold increase in the kcat, which led to the suggestion
that the enzyme evolved to maximize substrate recognition and speciﬁcity but not
catalytic turnover (264). Given that all heme synthesis enzymes exhibit similarly low
turnover rates, there appears to be no need to maximize catalytic efﬁciency.
As mentioned above, PgoX is found in relatively few Gram-negative bacteria, and
given its homology to Gram-positive CgoX, it is clearly derived from this family of
proteins. Structural comparison of the eukaryotic and Gram-negative protoporphyrino-
gen oxidases (PgoX) with the Gram-positive coproporphyrinogen oxidase (CgoX) re-
veals a less constricted active-site pocket for the Gram-positive enzyme, which allows
the binding of the larger and more charged coproporphyrinogen (209) (see above).
Unfortunately, and unlike bacterial ferrochelatases, there are no characteristic, deﬁning
motifs that allow one to differentiate PgoX from CgoX by amino acid sequence
alignments. However, realizing that PgoX is associated with PPD pathway-containing
bacteria and CgoX is associated with CPD pathway-containing bacteria, it is possible to
estimate that 65% of the members of this class of enzymes in bacteria whose genome
sequences are currently known are CgoX enzymes, and only 35% are PgoX enzymes
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(Table 2). Overall, PgoX is found in only about 16% of heme-synthesizing Gram-
negative bacteria.
Our knowledge of the oxygen-independent form of protoporphyrinogen oxidase
comes from early work done by the Jacobs laboratory (266–272). Those researchers
found that isolated membrane fractions of E. coli were capable of oxidizing protopor-
phyrinogen to protoporphyrin in the absence of oxygen so long as an electron acceptor
that could be utilized by the organism was present. A mutant of E. coli that lacked the
ability to oxidize protoporphyrinogen was isolated and characterized by Sasarman et al.
(273), and the gene was named hemG (here renamed pgdH1). This gene clearly is
involved in the activity documented by the Jacobs group and predated the identiﬁca-
tion and characterization of the oxygen-dependent PgoX enzyme described above.
PgdH1 has been found mainly in gammaproteobacteria such as E. coli and PPD-
possessing bacteria examined to date. From this analysis, it is clear that PgdH1 is found
in only about 20% of Gram-negative bacteria.
PgdH1 is a protein with similarity to long-chain ﬂavodoxins. It is distinct and
unrelated to PgoX (274). By convention, PgdH1 is a member of what is referred to as
the long-chain ﬂavodoxin family. Flavodoxins are a structurally and biophysically
well-characterized class of FMN-containing small-protein electron carriers (275, 276).
Thus, PgdH1, like AlaS, CgdH, and PgoX, represents an instance of patchwork evolution.
In comparison to characterized ﬂavodoxins, PgdH1 contains a 7-amino-acid residue
insertion between E. coli ﬂavodoxin A helix 3 and sheet 4. There is minimal primary
sequence identity between PgdH1 and other known ﬂavodoxins, and the ability of this
TABLE 2 Taxonomic distribution of enzymes speciﬁc for the siroheme-, coproporphyrin-, and protoporphyrin-dependent heme synthesis
pathways
Major taxon analyzed
No. of organisms capable
of heme biosynthesis
No. of UroD genomes per
taxon that utilize:
No. of UroD genomes per
taxon that utilize:
ChdC AhbD CgdH CgdC HemYa PgdH2 PgdH1
Total 645/651 153 61 390 387 231 326 99
Actinobacteria 81 83 16 2 79 1
Firmicutes 38 37 12 39
Chloroflexi (green nonsulfur bacteria) 7 6 3 2 1 7 2
Deinococcus-Thermus 9 9 2 2 1 9 1
Proteobacteria
Alphaproteobacteria 106 70 101 1 105 6
Betaproteobacteria 61 52 55 2 58 3
Gammaproteobacteria 163 2 3 136 144 11 70 82
Epsilonproteobacteria 27 27 25
Zetaproteobacteria 1 1 1 1
Deltaproteobacteria 19 13 4 4 17 1 2
Acidobacteria 3 3 1 1 1 3
Aquificae (class) 9 2 7 6 3
Armatimonadetes 1
Bacteroidetes-Chlorobi; Bacteroidetes 52 49 44 12 44
Bacteroidetes-Chlorobi; Chlorobi (green sulfur) 9 9 9 1
Chlamydiae-Verrucomicrobia group 10 2 7 6 10
Cyanobacteria 25 14 25 8 18
Deferribacteres 2 2 2
Gemmatimonadetes 1 1 1 1
Nitrospira 3 1 2 1 3
Planctomycetes 7 7 1 7
Spirochaetes 5 5 1 4 1
Synergistetes 1
Thermodesulfobacteria 2
Chrysiogenetes 1 1 1
Caldithrix 1 1 1
Thermobaculum 1 1
a“HemY” refers to the combined number of CgoX and PgoX enzymes.
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protein to oxidize protoporphyrinogen appears to reside in the so-called long-chain
loop region. Transferring a 22-residue-long segment from this region of PgdH1 into E.
coli ﬂavodoxin A confers PgdH1 activity to the ﬂavodoxin in vivo (274). PgdH1 has
speciﬁcity for protoporphyrinogen IX and does not oxidize uro- or coproporphyrino-
gen. PgdH1 does not directly utilize molecular oxygen but has been shown to interact
with the cell’s respiratory chain, hence the name protoporphyrinogen dehydrogenase.
This reaction not only catalyzes the formation of protoporphyrin but also may generate
cellular ATP, as the six electrons generated in the reaction can be funneled down the
respiratory chain (277). In vitro, this enzyme has been reported to utilize menadione,
triphenyltetrazolium chloride, ubiquinone, and menaquinone as well as to interact via
quinones with puriﬁed terminal oxidoreductases in the presence of their respective
substrates, although in vivo studies on menaquinone-deﬁcient E. coli mutants found no
evidence for the utilization of ubiquinone by PgdH1 (269).
A third protoporphyrinogen oxidase/dehydrogenase, PgdH2, was identiﬁed and
characterized in Synechocystis (278) and Acinetobacter (279). Genome-wide analyses
revealed that all heme-synthesizing Gram-negative bacteria that lack pgdH1 and pgoX
possess pgdH2 (38, 279). Thus, pgdH2 is the most commonly occurring form of
protoporphyrinogen oxidase, occurring in almost two-thirds of heme-synthesizing
Gram-negative bacteria. Unfortunately, relatively little is known about PgdH2. It is a
membrane-bound protein but may require a soluble factor for activity (278, 279). This
protein has not been puriﬁed to homogeneity, and there are no data to support the
presence or absence of a cofactor. Based upon the variety of heme-synthesizing
Gram-negative bacteria in which pgdH2 is found, it seems likely that it, like PgdH1, may
interact with cellular respiratory chains and not directly with an electron acceptor such
as O2. Interestingly, it was reported that pgdH2 does not complement an E. coli ΔpgdH1
mutant, suggesting that the mechanism of electron transfer from PgdH2 to the
respiratory chain is distinct from that for PgdH1 (279).
Metalation of protoporphyrin IX by protoporphyrin ferrochelatase (PpfC). The
terminal step in the protoporphyrin-dependent branch is the insertion of ferrous iron
into protoporphyrin IX. This is catalyzed by the enzyme protoporphyrin ferrochelatase
(PpfC). Although initial studies of this enzyme were done with metazoan sources (see
references 13 and 215), publications from as early as the 1960s described ferrochelatase
activity in the denitrifying bacterium P. denitrificans and the facultative photosynthetic
bacterium R. sphaeroides (280–283) as well as the yeasts Candida utilis and S. cerevisiae.
Later, characterization of the enzyme from R. sphaeroides demonstrated that it was
membrane associated and could utilize Co2, Zn2, Ni2, Mn2, and Fe2, but not
Fe3, as metal substrates and meso-, deutero-, and protoporphyrin IX as the porphyrin
substrates (284, 285). The fact that metal insertion was enzyme dependent rather than
non-enzyme dependent, as was suggested in the early 1960s (286, 287), was conclu-
sively demonstrated by the isolation and characterization of a heme auxotroph of
Aquaspirillum itersonii that lacked ferrochelatase activity (288).
Diverse but limited biochemical studies have been performed on the Gram-negative
protoporphyrin ferrochelatases from R. sphaeroides (289, 290), A. itersonii (291), B.
japonicum (292), Caulobacter crescentus (293), M. xanthus, Pseudomonas putida, Bdell-
ovibrio bacteriovorus (228), and A. aeolicus (263). In general, these enzymes all utilize
Co2, Zn2, Ni2, and Fe2 as metal substrates and deutero-, meso-, hemato-, and
protoporphyrin IX as the porphyrin substrates. While reported kinetic parameters vary
due to differences in assay conditions utilized among research groups, the Kms for both
the Fe2 and protoporphyrin IX substrates are in the 1 to 10 M range. Unfortunately,
at present, there are no crystal structures for any Gram-negative bacterial PpfC enzyme.
Earlier reviews of ferrochelatase stated that with the exception of the enzyme in
actinobacteria, most bacterial ferrochelatases do not possess a [2Fe-2S] cluster (215).
This was based upon a relatively small sample size of sequenced bacterial genomes
available at the time. Among these, a small number of ferrochelatases, as exempliﬁed
by those from M. xanthus, Bd. bacteriovorus, Azotobacter vinelandii, and P. syringae, have
a [2Fe-2S] cluster that is coordinated by 4 cysteine residues that are located within a
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20-residue internal segment (228). Interestingly, it appears from in silico modeling that
the cluster of these Gram-negative PpfCs may occupy a spatially similar site as that
found for the cluster of the human enzyme. The coordination by internal cysteines
varies from what exists for actinobacterial, metazoan, as well as a limited number of
Gram-negative bacterial (such as C. crescentus) ferrochelatases that have [2Fe-2S]
clusters that are coordinated by 3 cysteine residues located within the carboxyl-
terminal 30 residues and 1 internal cysteine residue. An examination of bacterial
genomes available in 2016 reveals that the carboxyl-terminal or internal cluster-
coordinating motifs are scattered and relatively rare among ferrochelatases of the
Proteobacteria. However, based upon sequence alignment models, the internal
coordination motif is found in ferrochelatases of the Bacteroidetes, Planctomycetes-
Chlamydia-Verrucomicrobia, Cytophaga, and Flavobacteria. Additionally, there is
anecdotal evidence suggesting that there may be a third cluster-coordinating motif
among some proteobacterial ferrochelatases. Thus, rather than being a rare feature
among bacteria, the [2Fe-2S] cluster may be more common than not. As mentioned
above, the speciﬁc role played by the [2Fe-2S] cluster in the ferrochelatases that
possess it is not currently known.
The mechanisms of action of all ferrochelatases would seem to be similar, although
only the human enzyme has a model for catalysis that is supported by kinetic and
structural data (217–221, 294) (Fig. 16). This model, which is based upon multiple
structures of variant and wild-type enzymes with and without bound porphyrin or
heme, projects that the enzyme active site exists in an “open” conformation to which
the porphyrin molecule binds (Fig. 16C and D). Binding of this substrate triggers a
rearrangement of a hydrogen bond network among conserved active-site residues
(possibly due to an abstraction of one of the pyrrole hydrogens by the enzyme), with
the result that the lips of the pocket close (“closed conformation”). This closure engulfs
the macrocycle and causes an 15° distortion of the bound porphyrin. This distortion
facilitates the chelation of the metal by the macrocycle to form the metallated heme
with the simultaneous displacement of the second pyrrole hydrogen to the conserved
histidine residue. The last act causes the movement of the imidazole side chain of the
conserved histidine that results in the unwinding of the conserved -helix, thereby
reopening the active site with an extension of the -helix (“release conformation”). This
allows/promotes product release.
As detailed above, it appears that one signiﬁcant difference between the copropor-
phyrin and protoporphyrin ferrochelatases is that one of the active-site lips that is
present in the protoporphyrin ferrochelatases is truncated in the coproporphyrin
ferrochelatases (Fig. 16B). The absence of the one lip would be anticipated to leave
open the active-site pocket even in the closed conformation, thereby allowing the
propionate side chains on the A and B rings of coproporphyrin to extend out. This
would explain why protoporphyrin ferrochelatases do not utilize coproporphyrin as a
substrate, but it does not explain why coproporphyrin ferrochelatases have such a poor
afﬁnity for protoporphyrin. Resolution of this issue will require additional crystal
structures of ferrochelatases with bound coproporphyrin.
The source and supply of ferrous iron for the metalation of tetrapyrrole by ferro-
chelatase are frequently overlooked in the discussion of heme synthesis. This is true
whether one is considering siroheme, coproheme, or protoheme synthesis. Microbial
iron metabolism is an active ﬁeld, including the acquisition and trafﬁcking of free iron
or heme-derived iron, yet few studies touch upon direct iron supply for ferrochelatases.
Given that ferrochelatases utilize ferrous, and not ferric, iron, both the transport and
reduction of iron for delivery to ferrochelatase must be considered. One of the few
examinations of this topic is also the earliest study that experimentally linked iron
reduction to heme synthesis in A. itersonii, R. sphaeroides, P. denitrificans, and E. coli
(295). By using the ferrous iron chelator ferrozine as an iron trap, it was found that ferric
iron reduction was linked to the cell’s respiratory chain in the organisms examined but
that there was not a stoichiometric link between iron reduction and heme synthesis
(296, 297). The identity of the enzyme(s) speciﬁcally involved in ferric iron reduction for
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heme synthesis in bacteria has not been elucidated, although a variety of ferric iron
reductases have been identiﬁed in metazoans.
Putative multienzyme complexes involving enzymes of heme synthesis in bacteria
are also poorly documented. For eukaryotes, there is an ever-increasing amount of data
to support the presence of multienzyme complexes for at least some heme synthesis
enzymes (298–301), but for bacteria, the only data available are those supporting a
complex involving PgoX and PpfC in the thermophilic cyanobacterium Thermosyn-
echococcus elongatus (302).
DIVERSITY OF HEME SYNTHESIS PATHWAYS AMONG PROKARYOTES
With the recent identiﬁcation of additional pathways to synthesize protoheme, along
with an explosion in the numbers of microbial genomes sequenced, it is now possible to
get a more comprehensive view of the diversity that exists among prokaryotes for the
biosynthesis of heme. Among microorganisms, the capacity to synthesize uroporphyrino-
gen III from ALA is extremely common but not ubiquitous. Among the analyzed set of 982
representative organisms, 9 archaea (17% of 54 genomes studied) and 120 eubacteria
(13%) lack recognizable homologs of any tetrapyrrole biosynthesis genes (see Tables
S1 to S3 in the supplemental material) (see http://pubseed.theseed.org//
SubsysEditor.cgi?pageShowFunctionalRoles&subsystemHeme_Biosynthesis%3A
_protoporphyrin-%2C_coproporphyrin-_and_siroheme-dependent_pathways). The com-
plete absence of a tetrapyrrole biosynthetic capacity (or incomplete pathways) appears
to result from secondary gene losses. This is not uncommon in various bacterial
pathogens and symbionts (e.g., in Mollicutes, Bacteroidetes, Bifidobacterium, or uncul-
tured termite group 1 bacterium phylotype Rs-D17) for which heme or other essential
tetrapyrrole compounds can be available from the host or other colonizing microor-
ganisms in the same niche. Other organisms lacking a tetrapyrrole biosynthetic capa-
bility are domesticated microorganisms living in rich and stable environments such as
milk (e.g., Lactobacillus, Leuconostoc, Lactococcus, and Streptococcus thermophilus), fruit
juice (Oenococcus), or sausage (Weissella) and selected for their fermentation capacity
when respiration, and, hence, the availability of heme, is nonessential. In free-living
organisms, however, the complete absence of tetrapyrrole biosynthesis is extremely
rare and occurs in only a few genera at the root of the eubacterial phylogeny
(Dehalococcoides, Thermotoga, and Thermoanaerobacterales) and in several classes of
Archaea (Table S3). The majority of these organisms are extreme thermophiles.
In sharp contrast to the nearly invariant tetrapyrrole pathway from ALA to URO III,
the conversion of URO III to heme has long been known to differ signiﬁcantly among
species. This multiplicity was puzzling until recent studies revealed that there are
multiple pathways of heme synthesis in prokaryotes. As detailed above, there are three
distinct pathways used to synthesize protoheme from uroporphyrinogen. With this
knowledge, a more informed analysis of the global phylogenetic distribution of the
known enzymes of heme biosynthesis becomes possible. By identifying unique enzyme
participants in each pathway, signature gene/protein patterns diagnostic for the pres-
ence of each of the 3 pathways are identiﬁable (see Tables S1 and S2 in the supple-
mental material). The selected proteins are (i) AhbA, AhbB, and AhbC for the siroheme-
dependent pathway; (ii) the coproporphyrinogen decarboxylases CgdC and/or CgdH
and the protoporphyrinogen oxidase PgdH1 or PgdH2 for the PPD pathway; and (iii)
ChdC for the CPD pathway. It should be noted that while only ChdC can be used as a
reliable diagnostic maker for the CPD route, some CPD pathway-possessing bacteria
may utilize AhbD in place of ChdC. Of the 806 (82% of the total) representative
prokaryotic genomes for which de novo URO III biosynthesis can be asserted, the
majority (713; 88.5%) also encode one of the 3 known routes for the production of
protoheme (Fig. 21), as deduced from the presence of the corresponding signature
genes (Tables S1 and S2). Only 8.8% of these 806 organisms lack any known heme
biosynthesis genes (71 out of 806), while a small fraction (22; 2.7%) contain unusual
combinations of such genes. The PPD route seems to be the most abundant, occurring
in over half of the analyzed genomes (471 out of 806; 58.4%), while the CPD and
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siroheme-dependent pathways are encoded in 166 (20.6%) and 76 (9.4%) genomes,
respectively. Thus, the 3 routes accurately describe heme biosynthesis for the vast
majority of the prokaryotic world with sequenced genomes available. However, the
observed relative occurrence ratios for the 3 pathways across the Prokaryota likely
FIG 21 Phylogenic distribution of the three currently characterized pathways for protoheme synthesis mapped onto the Tree of Life. The outside ring shows
(as vertical rectangles) the presence or absence of the siroheme-dependent branch (via Siro), the coproporphyrin-dependent branch (via Copro), or the classic
protoporphyrin-dependent branch (via Proto). Gray rectanglesmark the organisms that contain unusual combinations of genes normally involved in different pathways
for protoheme synthesis (hybrid paths). The distribution of the two routes used to synthesize 5-aminolevulinic acid (ALA) are also presented: the Shemin or C4 pathway
and the C5 pathway. The absence of a circle or square shows the inability of an organism to produce tetrapyrroles of any kind. Likewise, the absence of a rectangle
in the outside ring indicates the absence of any known route for protoheme synthesis in an organism. This illustration covers only 133 representative organisms (17
archaea, 110 eubacteria, and 6 eukaryotes) included in the Tree of Life (391, 392). A full analysis of the 978 representative microorganisms performed in this work is
available in the SEED subsystem “Heme Biosynthesis: Protoporphyrin-, Coproporphyrin-, and Siroheme-Dependent Pathways” (see http://pubseed.theseed.org//
SubsysEditor.cgi?pageShowFunctionalRoles&subsystemHeme_Biosynthesis%3A_protoporphyrin-%2C_coproporphyrin-_and_siroheme-dependent_pathways).
Mapped onto this tree, the siroheme-dependent pathway occurs largely in the Archaea, in the Thermodesulfobacteria, and, rarely, in several other taxa (see Table S3
in the supplemental material). The CPD route (teal) is found primarily in slow-evolving monoderm Firmicutes and Actinobacteria and in evolutionarily early-branching
(Acidobacteria, Planctomyces, and Aquificae) and transitional (Deinococcus-Thermus group) diderm phyla, while the PPD pathway has a wider distribution, occurring in
Proteobacteria, cyanobacteria, the Bacteroidetes-Chlorobi and Chlamydiae-Verrucomicrobia groups, Aquificae, Gemmatimonadetes, Caldithrix, and several other taxa. This
is the main route for protoheme production in the evolutionarily younger Proteobacteria, with an illuminating exception of the Deltaproteobacteria. Deltaproteobacteria
and epsilonproteobacteria are believed to be the oldest phyla within the Proteobacteria, with the other main proteobacterial groups being derived from them linearly
in a directional rather than in a tree-like manner in the order delta/epsilonproteobacteria ¡ alphaproteobacteria ¡ betaproteobacteria ¡ gammaproteobacteria (393).
Notably, the phylum Deltaproteobacteria is the only proteobacterial phylum in which all 3 routes leading to protoheme are represented in different species (Table S3).
A complete reconstruction of the heme biosynthetic pathways in the 38 representative deltaproteobacterial genomes is available online in the SEED subsystem (limit
view to “deltaproteobacteria”). As a few examples, genomes of Stigmatella aurantiaca and Myxococcus xanthus encode the PPD pathway, and genomes of Geobacter
metallireducens and Desulfuromonas acetoxidans harbor the CPD pathway, while genomes of Desulfovibrio vulgaris, Desulfatibacillum alkenivorans, and Desulfobacula
toluolica harbor the siroheme-dependent route.
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reﬂect the current uneven sampling of various microbial taxa for genome sequencing.
There are a few oddities, only 22 in the set of nearly a thousand, that do not clearly ﬁt
into the siroheme, CPD, or PPD pathways. In some cases, these deviations may be due
to errors in sequencing, assembly, or annotation. However, if the same unusual pattern
occurs in multiple genomes, it is likely a valid biological phenomenon and not an
artifact.
From an analysis of the bacterial genomes available in the SEED heme subsystem
(Fig. 21) (see Tables S1 to S3 in the supplemental material), one ﬁnds that among
representative examples, 82% of Actinobacteria possess the CPD pathway, 3% possess
the siroheme-dependent (ahbABCD) pathway, and 13% lack a functional heme biosyn-
thetic pathway (Table 2). Among the available genome sequences of representative
members of the Firmicutes, 62% lack a heme biosynthetic pathway, 15% have the
siroheme-dependent pathway, and 21% have the CPD pathway. Among members of
the Proteobacteria that possess the ability to synthesize heme, the vast majority utilize
the PPD pathway, with members of the Deltaproteobacteria being the outliers.
Organisms that possess multiple complete heme synthesis pathways are quite rare
in the currently available genomes. Methylomirabilis oxyfera is an example of an
organism with gene sets for both the siroheme-dependent and CPD pathways. There
are organisms in the Rhodobacteraceae (deltaproteobacteria) that possess genes for
both the CPD and PPD pathways. In these organisms, the CPD pathway utilizes ChdH,
and not AhbD, to convert coproheme to protoheme, while in the PPD pathway, both
CgdH and PpdH2 are present, suggesting that the PPD pathway may be favored by
these organisms under low-oxygen conditions. It should be noted, however, that there
are currently no biochemical data to support the presence of multiple, functional
pathways in any bacterium.
While the present review focuses largely on bacterial systems, it is of value to
observe what is known to exist in the Archaea. The CPD or PPD pathways have not been
found in archaea. In an analysis of representative members of the Archaea, 12 of 17
Crenarchaeota possess ahbABCD, and only 8 of 35 Euryarchaeota have ahbABCD (Table
3). As noted above, some ChdC-like proteins are present in genomes, but none are
associated with a complete set of heme-synthesizing enzymes (44). In addition, several
of them are fusion proteins with other unidentiﬁed proteins whose function is probably
not associated with heme synthesis.
REGULATION OF HEME BIOSYNTHESIS
There are considerable obstacles for any comprehensive review of the regulation of
heme biosynthesis in bacteria. Foremost among these are the existence of at least three
distinct pathways used to synthesize heme and wide metabolic diversity among
bacteria. Compounding this is that historically, studies of pathway regulation have been
based upon the assumption of a single classical pathway. Thus, data obtained in diverse
bacterial systems have sometimes been interpreted via an inaccurate pathway model.
Below, we present data that currently exist, realizing full well that it is an overly
simplistic approach that will necessarily change as future studies focus on distinctions
among the three protoheme-synthesizing systems.
The fact that prokaryotic heme synthesis is highly sensitive to environmental factors
is obvious to anyone who has noted the color of cell pellets and/or colonies on a plate
of facultative bacteria grown under conditions of high versus low aeration. Perhaps one
of the more profound visual examples is that of B. japonicum grown in liquid culture,
where modest levels of hemes are produced versus those found in leguminous nodules
that are bright red from the accumulation of leghemoglobin. Early studies on porphyrin
metabolism in microorganisms, as outlined previously (30), were limited to relatively
few organisms, with a major focus on the facultative photosynthetic bacterium R.
sphaeroides. This selection was based upon the fact that whereas other subject bacteria
such as M. lysodeikticus and P. denitrificans modulate their porphyrin content about
10-fold, the tetrapyrrole content in R. sphaeroides can vary over 100-fold. Depending
upon one’s view, the selection of R. sphaeroides as a model organism was either
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fortuitous or unfortunate. This is because R. sphaeroides, as an organism that possesses
AlaS (the C4, or Shemin, pathway) as the major rate-limiting step in tetrapyrrole
synthesis, is not representative of the majority of bacteria and archaea that were later
shown to utilize the C5 pathway to synthesize ALA. Also, as a model for the regulation
of heme synthesis, R. sphaeroides introduces the confounding issue that it utilizes
tetrapyrrole synthesis for both chlorophyll and heme. Following the discovery of the C5
pathway for ALA synthesis that employs the enzymes GtrR and GsaM, it was shown that
the overproduction of GtrR in E. coli results in the accumulation of ALA and porphyrins
(303). This suggested that GtrR serves a regulatory role in heme synthesis in organisms
that possess the C5 pathway. Thus, whatever the organism, the clear consensus was
that the biosynthesis of ALA, the ﬁrst committed compound of the pathway, is the key
rate-limiting step in tetrapyrrole synthesis.
Regulation of Heme Biosynthesis by Iron
Iron can be a limiting nutrient, and protoporphyrin and other heme precursors can
be toxic. These facts make a strong prima facie argument for the regulation of heme
biosynthesis by iron to prevent porphyrin synthesis from exceeding iron availability.
Starting with Pappenheimer in 1947 (304), there have been numerous studies demon-
strating the impact of iron limitation on heme synthesis. Interestingly, many of those
studies reported that under iron limitation, coproporphyrin, and not protoporphyrin,
TABLE 3 Taxonomic distribution of three pathways used to synthesize protoheme
Major taxon analyzed
No. of genomes analyzed
(in the 981-taxon set)









Crenarchaeota 17 3 12
Euryarchaeota 35 19 8
Actinobacteria 99 13 3 81
Firmicutes 179 112 27 38
Chloroflexi (green nonsulfur bacteria) 11 2 1 6 2
Thermotogae 10 10
Deinococcus-Thermus 10 8 1
Proteobacteria
Alphaproteobacteria 109 4 106
Betaproteobacteria 62 1 61
Gammaproteobacteria 174 11 4 159
Epsilonproteobacteria 27 27
Zetaproteobacteria 1 1
Deltaproteobacteria 38 19 13 5
Acidobacteria 4 1 3
Aquificae (class) 9 2 7
Armatimonadetes 1
Bacteroidetes-Chlorobi; Bacteroidetes 70 15 51
Bacteroidetes-Chlorobi; Chlorobi (green sulfur) 9 9





Nitrospira 3 2 1
Planctomycetes 7 7
Spirochaetes 18 13 5
Synergistetes 9 7 2
Thermodesulfobacteria 2 2
Chrysiogenetes 1 1
Tenericutes; Mollicutes 17 17
Caldithrix 1 1
Thermobaculum 1
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accumulates in the growth medium (30). This is not surprising for the Actinobacteria
and Firmicutes, which lack the ability to synthesize protoporphyrin (35). However, the
Gram-negative bacterium R. sphaeroides also accumulates large amounts of copropor-
phyrin (30). It was found that additions of low levels of iron, considerably lower than
what would be required to form a stoichiometric amount of heme from the excreted
coproporphyrin, largely eliminated the accumulation of coproporphyrin (305). It was
suggested that the heme formed from the added iron served to inhibit AlaS and reduce
the overproduction of porphyrin (306). Why this was coproporphyrin rather than
protoporphyrin in this organism has never been completely explained. The nonpho-
tosynthetic Gram-negative bacteria E. coli and P. denitrificans were noted to accumu-
late coproporphyrin and protoporphyrin in amounts that are responsive to the
nature of the available terminal electron acceptor, although in all cases, the amount
of coproporphyrin found in the medium signiﬁcantly exceeded the amount of
protoporphyrin (267, 272).
Surprisingly, iron-based transcriptome and proteome analyses of numerous bacte-
rial species failed to turn up heme biosynthesis genes and proteins (142, 307–315). In
these cases, either gene expression is not regulated by iron or one or more other factors
are limiting or in excess under the growth conditions used, which could mask the
effects of iron. Iron-dependent control of heme biosynthesis genes has been described
for the rhizobiales and R. capsulatus.
In B. japonicum, Rhizobium leguminosarum, and Brucella abortus, the iron response
regulator (Irr) protein coordinates the heme biosynthetic pathway with iron availability
to prevent the accumulation of toxic porphyrin precursors under iron limitation (316–
318). A loss of function of the irr gene is sufﬁcient to uncouple the pathway from
iron-dependent control, as discerned by the accumulation of protoporphyrin under
iron limitation (316, 317). In B. japonicum, Irr accumulates to a high level in iron-limited
cells to negatively regulate heme biosynthesis at pbgS and alaS, the genes encoding
the heme biosynthetic enzymes porphobilinogen synthase (PbgS) and ALA synthase,
respectively (316, 319). Predicted Irr-binding sites are found upstream of the alaS gene
in many species of the Rhizobiales (318), the taxonomic order that includes the rhizobia,
Brucella, and Agrobacterium.
Irr does not sense iron directly; rather, it perceives and responds to an iron-
dependent catalytic reaction, namely, the synthesis of heme. Protoporphyrin ferroche-
latase catalyzes the insertion of iron into protoporphyrin to form heme in the ﬁnal step
of the heme biosynthetic pathway in Gram-negative bacteria. Irr interacts directly with
ferrochelatase and responds to iron via the status of heme and protoporphyrin local-
ized at the site of heme synthesis (320). Under iron-replete conditions, Irr forms a
complex with ferrochelatase. Heme synthesized by ferrochelatase binds to speciﬁc sites
on Irr, leading to the degradation of Irr (320, 321). The understanding of the mechanism
by which heme triggers Irr degradation is incomplete, but evidence supports the
conclusion that heme catalyzes Irr oxidation, leading to turnover (319, 321). When iron
is limiting, ferrochelatase will be bound by protoporphyrin only, and it cannot form a
complex with Irr, leaving Irr free to regulate genes under its control (Fig. 22). Thus, Irr
senses heme directly through binding to heme and to protoporphyrin and iron
indirectly through its interaction with ferrochelatase. This mechanism bypasses the
need to invoke a free-heme pool, a concept not readily compatible with the cytotoxicity
of heme, and it may represent the simplest type of heme signaling because there is no
obvious need for a factor to chaperone heme from the site of synthesis to its target.
Heme exerts an effect on the activation function of B. japonicum Irr in vivo in addition
to its role in degradation, but it does not impair Irr occupancy of target genes; hence,
DNA binding must remain intact (322). The Irr protein from R. leguminosarum binds
heme, but the cellular Irr level is not diminished in response to iron (323). In vitro studies
show that binding of heme to Irr inhibits its DNA-binding activity.
Irr was initially identiﬁed in a genetic screen for mutants defective in the control of
the heme biosynthetic pathway, but it is now known to be a global regulator of
iron-responsive genes (318, 319, 324). This means that iron homeostasis and metabo-
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lism are regulated by an iron-intensive process rather than by iron directly. Transcrip-
tome analyses show that, at least in B. japonicum, Irr has a large regulon and that most
genes strongly controlled by iron at the mRNA level are also regulated by Irr (319). Irr
is present and active under iron limitation, and genes under positive control are
involved in iron acquisition and other functions that allow adaptation to this environ-
ment. Irr represses genes encoding proteins that function optimally under iron-replete
conditions, including those that contain iron, synthesize heme and iron-sulfur clusters,
and respond to high-iron stress (210, 274, 318, 324–332).
Global transcriptional control by iron is mediated by the Fur protein in E. coli and in
many other bacteria, and Irr-mediated regulation appears to be conﬁned to the
Alphaproteobacteria (333). Fur binds iron directly, which confers DNA-binding activity
on the protein. The discovery that Irr is a global iron regulator raises the question as to
why the rhizobia and related alphaproteobacteria employ a complex iron-sensing
mechanism when, from a naive perspective, a simple one should sufﬁce. The rhizobia
have coopted a Fur homolog to respond to manganese instead of iron, and it has been
renamed Mur (manganese uptake regulator) (334–338). This is consistent with other
ﬁndings suggesting that B. japonicum and its relatives are more reliant on manganese
than are other bacteria (311, 336, 339, 340). Interestingly, B. japonicum Mur behaves as
an iron-responsive regulator when expressed in E. coli cells (341), suggesting that the
cellular environment confers metal speciﬁcity. Consistent with this, E. coli Fur responds
to manganese and not iron in B. japonicum cells (341). Thus, adaptation to manganese
likely results in a cellular milieu that prohibits Mur (or Fur) from responding to iron,
thereby requiring a different sensing strategy, as observed for Irr.
B. japonicum cells grown under low-iron conditions respire and synthesize heme
proteins, and therefore, heme biosynthesis genes cannot be completely repressed by Irr.
However, the Irr-repressible gene encoding the iron exporter protein MbfA is needed only
under high-iron stress and appears not to have a housekeeping role (330). This ﬁnding
suggests that genes within the Irr regulon must be differentially regulated. This problem
appears to be solved, at least in part, with promoters of Irr regulon genes with a wide range
of afﬁnities for the regulator (Fig. 23) (322). pbgS and other housekeeping genes have
promoters with a weak afﬁnity for Irr to ensure some level of expression even under the
repressing conditions of iron limitation. In contrast, bacterioferritin and MbfA are important
in managing high-iron stress (330, 342); hence, strong repression of genes that encode
them is appropriate under conditions of low or moderate iron levels, with derepression
occurring only under conditions of high iron levels. This control is achieved with bfr and
mbfA gene promoters that bind Irr with high afﬁnity (322).
FIG 22 Irr senses iron indirectly through the status of heme biosynthesis. Under high-iron conditions, Irr
forms a complex with protoporphyrin ferrochelatase (FC), which inactivates Irr, followed by heme-
dependent degradation. Heme is represented in red, and protoporphyrin is shown in blue. Under
low-iron conditions, ferrochelatase is bound to protoporphyrin but not iron, and ferrochelatase cannot
form a complex with Irr. In Rhizobium leguminosarum, Irr is not degraded in response to iron, but heme
inhibits DNA binding.
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Regulation of Heme Biosynthesis by Heme
Biosynthetic pathways are often regulated by their end product, and heme controls
its own synthesis at the levels of transcription, protein stability, and enzyme activity.
However, there does not appear to be a universal model or mechanism that is widely
distributed throughout the bacterial kingdom. Interestingly, most sites of regulation
characterized to date occur with early pathway enzymes.
B. japonicum Irr responds to heme as described above to mediate iron control of
heme biosynthesis. Expression levels of pbgS and other genes normally repressed by Irr
are constitutively low in a heme biosynthesis mutant because Irr is not degraded (319,
322). Thus, heme does not serve as a feedback mechanism to downregulate its own
synthesis. Rather, Irr responds indirectly to the substrates of heme synthesis, protopor-
phyrin and iron, by interacting with ferrochelatase. Thus, it responds to the status of the
synthesis of heme and not merely the product.
The gtrR gene of the ﬁrmicute Corynebacterium diphtheriae is negatively regulated
by heme through the actions of the two-component regulatory systems ChrA-ChrS and
HrrA-HrrS (343). These regulatory systems were originally discovered in studies to
elucidate the mechanism of positive control of the heme oxygenase (hmuO) gene by
heme and hemoglobin (344, 345). Heme oxygenase catalyzes the degradation of heme
for use as an iron source, and the positive control of hmuO by heme makes physio-
logical sense. ChrA is a response regulator, and ChrS is the sensor histidine kinase that
responds to the heme status. Mutations in genes encoding these proteins diminish but
do not abolish activity, which led to the search for and discovery of HrrA and HrrS. A
loss of function in both systems abolishes the control of hmuO and gtrR. In the related
organism Corynebacterium glutamicum, HrrA/HrrS controls numerous steps in heme
biosynthesis as well as heme acquisition from the environment (346). Collectively, the
ﬁndings show that the biosynthesis of heme and its subsequent metabolism are
coordinately controlled in Corynebacterium species.
The expression levels of several heme biosynthesis genes in R. capsulatus that are
upregulated by the transcriptional regulator are downregulated by heme (347). More-
over, HbrL binds heme directly (347), suggesting that heme attenuates the activation
function of HbrL. Heme has also been shown to directly inhibit the activity of R.
sphaeroides AlaS in vivo (306).
The glutamyl-tRNA reductase (GtrR) protein of Salmonella enterica serovar Typhi-
murium is destabilized by heme, resulting in a 25-fold increase in protein levels in
heme-starved cells, with only a 2-fold change in gtrR promoter activity (348, 349).
Heme-dependent degradation of GtrR is lost in mutants defective in genes encoding
the Lon and ClpAP proteases. Cysteine 170 of GtrR was shown to be necessary for heme
binding, and a C170A mutant protein is constitutively expressed in vivo (350).
Heme inhibits GtrR activity in cell extracts from several bacterial species by an
allosteric feedback mechanism. Recombinant GtrR from Chlorobium vibrioforme is a
homodimer puriﬁed as a recombinant protein from E. coli. It contains one tightly bound
FIG 23 Differential control of Irr-repressed genes by the variable afﬁnity of Irr for target promoters.
Low-afﬁnity promoters such as those found in the housekeeping gene leuC or pbgS allow some
expression (derepression) even under low-iron conditions, where Irr levels are highest. High-afﬁnity
promoters such as those found for mbfA and bfr repress expression strongly at low and intermediate
levels of iron and are derepressed only at high iron levels.
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heme molecule per monomer, and heme inhibits activity in vitro (351). GtrR levels are
diminished by ALA supplementation in Acidithiobacillus ferrooxidans (352). Synechocys-
tis sp. strain PCC6803 with diminished ferrochelatase activity accumulates protopor-
phyrin and has elevated ALA synthesis activity (353). This mutant grows normally and
synthesizes phycobilins, which are derived from heme. It is likely that the diminution in
heme synthesis in the mutant is not severe enough to limit heme for most cell
functions, but it is below a level needed to allosterically inhibit ALA synthesis, presum-
ably at GtrR (353).
ALA synthesis by the C5 pathway is initiated by the charging of tRNAGlu with
glutamate by glutamyl-tRNA synthetase (GluRS), which is not a committed step in
tetrapyrrole formation because it also is used in protein synthesis. Therefore, it is
surprising that GluRS is regulated by heme status in A. ferrooxidans, an organism that
can accumulate 9-fold more heme when grown with ferrous iron as an electron donor
than can E. coli cells (352). In this organism, heme affects both the protein levels and
enzyme activity of GluRS. Interestingly, and perhaps coincidentally, heme also binds to
human arginyl-tRNA synthetase (ArgRS), even though this enzyme is not involved in
heme biosynthesis (209). ArgRS is the source of arginine in arginyltransferase activity for
targeting proteins for degradation via the N-end rule of protein degradation. Heme
promotes ArgRS oligomerization, which may contribute to the inhibition of enzyme
activity.
Regulation of Heme Biosynthesis by Oxygen
AlaS of R. sphaeroides was shown to be sensitive to negative-feedback inhibition by
micromolar concentrations of heme (306), and its activity in whole cells was sensitive
to oxygen tension (354). The second observation was expanded by Neuberger’s group
in a series of papers (355–357). That group demonstrated that AlaS from cell extracts
could be resolved into two fractions, high-activity and low-activity enzyme fractions.
The ratio of these two forms was oxygen sensitive, with a preponderance of the
low-activity form occurring in cells that had been grown under high aeration and the
high-activity one being the major form in cells grown under low aeration. It was further
demonstrated that in vitro, the low-activity form is converted to the high-activity form
by cystine trisulﬁde or the mixed trisulﬁde of cystine and glutathione. The model
proposed for this was that the trisulﬁde compound reacted with the enzyme to
produce a protein-bound persulﬁde or trisulﬁde, which somehow activated the en-
zyme. The modulation of this activation is attributable to the regulation (decrease) of
the trisulﬁde concentration by (increased) oxygen tension. Unfortunately, in the ensu-
ing 4 decades, no additional studies have further tested this model by identifying the
site and nature of the AlaS posttranslational modiﬁcation (PTM) or to determine how
the trisulﬁde level is regulated.
In animals and fungi, hypoxia or anaerobiosis is associated with fermentative metabo-
lism, since oxidative phosphorylation is strictly dependent on O2. Thus, oxygen and heme
are positively correlated. Furthermore, three heme biosynthetic enzymes, coproporphy-
rinogen III decarboxylase (CgdC), coproporphyrinogen oxidase (CgoX), and protoporphy-
rinogen IX oxidase (PgoX), use O2 as a substrate. In fact, O2 control of genes involved in
aerobic metabolism occurs indirectly through heme in S. cerevisiae (358). For many pro-
karyotes, however, this correlation is not observed, because they can use electron acceptors
other than O2 to support oxidative respiration. In addition, some bacteria have cytochrome
oxidases with a very high afﬁnity for O2, conferring to them the ability to grow under
oxygen limitation. Thus, hypoxia or anaerobiosis does not necessarily trigger a switch to
fermentative metabolism and may actually require an increase in tetrapyrrole synthesis.
Moreover, most heme-synthesizing Gram-negative bacteria have an O2-independent co-
proporphyrinogen III dehydrogenase (CgdH). Finally, low O2 levels are a cue to induce
photosynthesis-related genes in bacteria, which requires enzymes common to heme and
chlorophyll synthesis. Photosynthesis requires steps in tetrapyrrole synthesis for chlorophyll
synthesis and also for electron transfer reactions.
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The regulation of tetrapyrrole synthesis genes by oxygen in R. sphaeroides and R.
capsulatus is under the control of numerous regulatory circuits for photosynthetic and
anaerobic metabolism (40). The fnrL locus was identiﬁed in a mutant screen for elevated
alaS gene expression levels under aerobic conditions and is required for photosynthetic
growth and anaerobic growth with dimethyl sulfoxide (359, 360). FnrL binds to both
promoters of alaS for the anaerobic induction of this gene (361). Moreover, FnrL affects
numerous other genes in heme biosynthesis in both R. sphaeroides and R. capsulatus
(216, 362). In addition to FnrL, the two-component response regulator PrrA (RegA) has
been shown to control heme synthesis gene expression in Rhodobacter (216, 362, 363).
PrrA/RegA responds to the cellular redox state to control anaerobic metabolism in
numerous bacterial species. PrrA binds to both promoters of R. sphaeroides alaS under
aerobic conditions, but anaerobic activation requires binding to the P2 promoter (363).
PpsR/CrtJ is a repressor of photosystem development under aerobic conditions, and
this transcriptional regulator also controls numerous heme synthesis genes (362, 364).
R. sphaeroides contains two putative hemN (cgdH) gene homologs encoding O2-
independent coproporphyrinogen dehydrogenases, designated cgdH1 (hemN1) and
cgdH2 (hemN2 or hemZ) (359). hemN1 is negatively regulated by the outer membrane
protein TspO, apparently by a posttranscriptional control mechanism (365). TspO also
negatively regulates carotenoid and bacteriochlorophyll production aerobically, and so
cgdH1 may be primarily involved in chlorophyll synthesis.
Rhizobia can establish symbiosis with leguminous plants, which culminates with the
development of a specialized plant organ called a root nodule. The bacteria convert
atmospheric nitrogen to ammonia to fulﬁll the nutritional nitrogen requirement of the
plant host. The oxygen tension within a nodule is very low, and this serves as a signal
for the induction of genes necessary for nitrogen ﬁxation and microaerobic metabo-
lism. De novo heme biosynthesis for the synthesis of cytochrome cbb3 oxidase and
other cytochromes is required for microaerobic metabolism, hence the need to control
heme biosynthesis. The RegRS system in B. japonicum is homologous to the RegAB/
PrrAB proteins in Rhodobacter. Although heme synthesis is regulated by O2 in B.
japonicum and is phylogenetically related to Rhodobacter, the RegR regulon does not
appear to include heme synthesis genes, as judged from transcriptional proﬁling data
(366). Rather, O2 control of heme synthesis and cytochrome production occurs by a
regulatory cascade initiated by another two-component regulatory system, FixLJ. FixL
senses O2 directly by binding directly to the protein via a heme moiety (367). Deoxy-
genated FixL phosphorylates FixJ to activate target genes, including fixK2, encoding a
Crp/Fnr family regulator. FixK2 positively controls alaS, pbgS, and cgdH and is also
needed to downregulate cytochrome aa3 levels, which are not needed in microaerobic
nodules (366, 368–371). B. japonicum also has two putative hemN (cgdH) genes,
designated hemN1 and hemN2 (369). Neither gene is expressed aerobically, but both
genes are strongly induced under microaerobic or anaerobic conditions. A hemN1
mutant does not have a discernible phenotype, but a hemN2 mutant is unable to grow
anaerobically on nitrate and does not elicit functional nodules on its plant host (369).
The presence of multiple hemN homologs and control by Fnr-like proteins are not
conﬁned to the alphaproteobacteria Rhodobacter and Rhizobium. A hemN gene of P.
aeruginosa is under the control of two Fnr-type regulators, Dnr and Anr, both of which
are needed for anaerobic induction (372). The hemN gene in this organism is also
expressed aerobically, which is dependent only on Anr. Surprisingly, the cgoX gene
encoding the O2-dependent oxidase is also strongly induced by anaerobiosis in an Anr-
and Dnr-dependent manner. Unfortunately, hemN has frequently been inappropriately
assigned the annotation of being an “oxygen-independent coproporphyrinogen oxi-
dase” without appropriate biochemical support (35). Thus, many proposed HemNs are,
in fact, not bona ﬁde CgdH enzymes. Some annotated HemN proteins are known to be
HemW, a heme chaperone (reviewed in reference 35), and ChuW, an oxygen-
independent heme-degrading enzyme (373). This makes the interpretation of reported
putative heme regulation data even more challenging.
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Regulation of Heme Biosynthesis by Reactive Oxygen Species
The generation of reactive oxygen species (ROS) is a consequence of aerobic
respiration as a result of the partial reduction of molecular oxygen and the
subsequent reactions of these products with transition metals and other com-
pounds (374). The environment can also be a source of ROS given the permeability
of bacterial membranes to hydrogen peroxide (375). Superoxide (O2) and hydro-
gen peroxide (H2O2), the initial partial reduction products of oxygen, can damage
cell components but to only a limited extent. However, O2 is capable of destroying
exposed iron-sulfur clusters with the release of free iron, and the released iron
subsequently reacts with H2O2 via the Fenton reaction, generating extremely
reactive hydroxyl radicals (HO˙). Hydroxyl radicals can directly attack most macro-
molecules such as DNA, lipids, and proteins, which is the basis of oxygen toxicity
(reviewed in reference 376).
Bacteria have multiple defense strategies against oxidative stress, including the
direct detoxiﬁcation of ROS by catalase, peroxidases, and superoxide dismutase. Cata-
lase and peroxidases are heme proteins, and their synthesis must be maintained or
perhaps elevated under oxidative stress. Oxidative stress responses require the activa-
tion of regulatory proteins and the induction of genes under their control. In many
bacteria, the transcriptional regulator OxyR senses H2O2 through disulﬁde bond for-
mation that locks the protein in an active conformation (377). In E. coli, the ppfC and
cgdC genes, encoding ferrochelatase and the O2-dependent coproporphyrinogen
oxidase, respectively, are induced in response to H2O2 stress by OxyR-dependent
activation (378, 379). H2O2 stress induces iron limitation by sequestration by the
DNA-protective, iron storage protein Dps (DNA-binding protein under starvation) in
order to minimize Fenton chemistry that creates hydroxyl radicals from H2O2 and
Fe2. Elevated ferrochelatase levels may allow the enzyme to compete with Dps for
iron for heme synthesis (378). Additionally, CgdH is an iron-sulfur cluster-containing
protein whose clusters are susceptible to H2O2 damage (380), and its synthesis may
be compromised under iron limitation induced by H2O2 stress. These cellular
responses underscore the roles that iron plays as both a problem and a solution in
managing H2O2 toxicity.
In B. subtilis, PerR is the major peroxide regulator and represses a large PerR regulon
(381). The OhrR family of antioxidant regulators is responsible for organic hydroperox-
ide resistance (382). B. subtilis PerR is an H2O2-responsive transcriptional repressor
belonging to the Fur family of metalloregulators (383). The oxidation of PerR by H2O2
inactivates it, resulting in the derepression of its regulon. These genes include the
hemAXCDBL operon, encoding enzymes for the early steps of heme synthesis (384, 385).
Heme synthesis in response to H2O2 provides the prosthetic group for the catalase
KatA. A perR mutation has a growth phenotype that is contributed by heme seques-
tration due to derepression of the katA gene (386). This ﬁnding suggests that a
substantial quantity of heme produced is committed to KatA synthesis. B. japonicum Irr,
a Fur family protein, is also affected by H2O2, by promoting its degradation (319, 322).
A loss of Irr derepresses alaS, pbgS, and the major catalase gene katG (319).
Unexplored Territory
Over the past decade, studies have revealed that a multitude of metabolic
pathways are subject to regulation by PTM. For bacteria in particular, a growing
body of data has implicated reversible lysine acetylation as an essentially universal
modulator of pathways (387), whereas in eukaryotes, one also frequently ﬁnds
lysine succinylation (388). In addition, for pathways that are sensitive to oxygen and
or redox potential, cysteine glutathionylation is not infrequently encountered (389).
PTM regulatory mechanisms have yet to be studied for bacterial heme biosynthesis,
but one would anticipate that these mechanisms exist and play a signiﬁcant role in
heme homeostasis in bacteria.
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ONE MODEL FOR THE EVOLUTION OF TETRAPYRROLE BIOSYNTHESIS AND
SOME PIECES THAT ARE STILL MISSING
The manner in which the various pathways for heme synthesis evolved has led to a
number of models that each tried to resolve the question based upon currently
available data. This topic has most recently been reviewed by Ducluzeau and Nitschke
(36). Unfortunately, that overview lacked information about the CPD pathway and
therefore fell short in its ﬁnal proposal. Assuming that there are no major revelations
about the diversity of heme synthesis, we believe that some simple observations can be
made.
The most ancient of the tetrapyrrole biosynthetic pathways exists in the Archaea.
Here one ﬁnds the ability to synthesize ALA from glutamyl-tRNA and the presence of
the core pathway enzymes to make uroporphyrinogen III. This core set of enzymes is
highly conserved from the Archaea through bacteria to eukaryotes, suggesting that all
tetrapyrrole-synthesizing organisms descended from a common pathway. There was a
primitive chelatase (similar to CbiXs) that evolved to function with different tetrapyr-
roles and a variety of metals (184, 185, 213). Among the Archaea, pathways for the
synthesis of cobalamin (Co), F430 (Ni), and siroheme (Fe) evolved. Siroheme appears to
be the most ancient surviving iron-containing tetrapyrrole, although the possibility that
a less decorated iron-containing tetrapyrrole structure ﬁrst evolved cannot be ruled
out. The ability to modify siroheme into heme d1 and protoheme resulted in the ﬁrst
appearance of protoheme in nature (11). Interestingly, this pathway led through
coproheme III, which was not adopted as a cofactor and, thus, was clearly less ideal for
the biochemical processes involving heme than was protoheme.
Among eubacteria, UroD is ﬁrst found as an extension of the common pathway from
uroporphyrinogen III to protoheme (35, 43). CgoX, CpfC, and ChdC appear in the
ﬁrmicutes and actinobacteria to form protoheme via coproheme, and this pathway
exists in some ancient Gram-negative bacteria. The siroheme-dependent pathway to
protoheme (AhbABCD) persists for a limited number of eubacteria, but AhbD of this
pathway is more widely adopted by the CPD pathway as an apparent anaerobic
alternative to ChdC. Nevertheless, no Gram-positive organism that has the ability to
synthesize protoporphyrin has currently been identiﬁed. The switch from the CPD
pathway to the PPD pathway is an interesting one without explanation at present, but
a recent report that ChdC stimulates CgoX to oxidize protoporphyrinogen to proto-
porphyrin may provide an interesting ﬁrst clue (390).
In Gram-negative bacteria, after a coproporphyrinogen “oxidative decarboxylase”
(CgdH/CgdC) became available to synthesize protoporphyrinogen IX, CdoX evolved a
speciﬁcity for protoporphyrinogen IX over coproporphyrinogen III to become PgoX,
and a select set of bacteria evolved PgdH1 from a ﬂavodoxin to replace PgoX, while the
majority of Gram-negative bacteria evolved PgdH2 for this purpose. CpfC evolved to
PpfC with a speciﬁcity for protoporphyrin. It is difﬁcult to see what drove these various
evolutionary alterations, but the major result was the availability of protoporphyrin, a
necessity for chlorophyll biosynthesis.
Finally, in a limited number of bacteria, AlaS replaces GtrR plus GsaM. The last
change may represent the evolutionary conversion of GsaM to AlaS (77). The ultimate
outcome of such an event was the elimination of one enzyme (GtrR) and the switch of
the ALA precursor from glutamyl-tRNA to succinyl-CoA. Among the 806 organisms
contributing to the SEED representative genome set (see Table S3 in the supplemental
material), 102 (12.6%) possess the C4 route catalyzed by AlaS, 680 (84.4%) contain the
C5 route (encoded by GtrR and GsaM), 5 (0.6%) encode both pathways, and 19 (1.9%)
have neither. The one-step pathway to ALA that utilizes succinyl-CoA plus glycine
rather than depleting the cellular pool of glutamyl-tRNA apparently proved to be
beneﬁcial and spread by horizontal gene transfer (HGT) to some organisms already
possessing the C5 route. Only a few genomes in the SEED collection of 983 genomes
encode both functional pathways: Chromobacterium violaceum ATCC 12472, Serratia
proteamaculans 568, Pseudomonas fulva 12-X, Streptosporangium roseum DSM 43021,
and Streptomyces griseus NBRC 13350. These organisms belong to four different classes
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(Actinobacteria, Betaproteobacteria, Gammaproteobacteria, and Firmicutes) and repre-
sent rare events in their respective taxonomic groups, where the majority of members
encode exclusively the C5 route (from 0.4% to 1.5% of genomes analyzed outside the
representative set). There are no clear examples of HGT events in the opposite direction
(i.e., that of an organism in the AlaS-possessing class of Alphaproteobacteria acquiring
the 2-step C5 pathway).
From a distance, it may appear that the jigsaw puzzle of bacterial heme synthesis is
largely complete, but there are still a few crucial missing pieces. The most obvious of
these is in the CPD pathway, where only an oxygen-dependent enzyme (CpoX) has
been identiﬁed to convert coproporphyrinogen into coproporphyrin. Given that a
number of CPD-containing organisms are capable of heme synthesis under anaerobic
conditions, it is clear that an oxygen-independent form of CpoX must exist, just as there
are oxygen-dependent and oxygen-independent forms of protoporphyrinogen oxidase
for the PPD pathway. Whole-genome studies hint that a gene encoding such a protein
may exist in the DUF1444 superfamily of the Firmicutes, but no biochemical studies
have veriﬁed this possibility, and interestingly, no such protein appears in the Actino-
bacteria.
There also are major deﬁciencies in our knowledge of the catalytic mechanism for
many pathway enzymes. While X-ray crystal structures exist for a majority of pathway
enzymes, there are only a few structures of enzymes with the substrate or product
bound. These data are essential since, as clearly outlined above for ferrochelatase and
as suggested for HmbS, molecular rearrangements are a requirement for catalysis by
some enzymes. For the enzymes AhbD, PgdH1, and PgdH2, there are currently no
structures and little catalytic information. Additionally, little is known about possible
multiprotein complexes among the enzymes of the core or any of the three branches
(87, 302), although limited data suggesting that “metabolons” exist for heme synthesis
proteins in eukaryotic mitochondria are now available (300).
Without a doubt, the largest “black box” for all three biosynthetic pathways to
protoheme is an understanding of regulatory mechanisms. For instance, the half-
century-old observation that coproporphyrin is commonly excreted by many bacteria
under certain growth conditions is still not understood or explained. Is this a common
random event, or is the coproporphyrinogen purposefully overproduced to serve a
speciﬁc biological function, perhaps as an emergency electron sink? Given the diversity
of cellular metabolism among heme-synthesizing prokaryotes, it is obvious that the
regulatory mechanisms employed to modulate heme homeostasis are quite diverse,
and lessons learned from an individual group of organisms may not be applicable to
others. This, then, is the major challenge going forward and should occupy researchers
for decades to come.
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